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Introduction: Vitamin D is a fat-soluble vitamin, classified as 9.10-secosteroid hormone 
precursor. Current research has revealed that optimal vitamin D status may be essential 
for a range of skeletal and non-skeletal outcomes. Vitamin D status was defined as 
sufficient (>30ng/mL), insufficient (20–30ng/mL) and deficient (<20ng/mL) for the purpose 
of this study. Data on 25(OH)D in South African adults is limited and vitamin D status 
assessment in the pre-operative adult orthopaedic patient has not yet been done. This 
study aimed to determine the vitamin D status of orthopaedic surgical patients and the 
impact of the surgical intervention on vitamin D status after the recovery period, as well as 
to determine the relationship between vitamin D status and demographic parameters, 
anthropometrics, sun exposure and vitamin D intake. 
 
Methods: During the study period (April 2014–September 2014) patients were identified 
from orthopaedic surgical lists at Mulbarton Hospital, Johannesburg. Pre-operatively 
anthropometric measurements and relevant questionnaires (demographic, skin 
classification, sun exposure (calculated sun index) and short food questionnaire for vitamin 
D) were completed. Biochemical analysis of vitamin D was done pre-operatively. At a 
follow-up screening, vitamin D status, sun exposure and questionnaire for vitamin D intake 
were repeated. 
 
Results: A total of 67 patients (67.2% females) were included. Average age was 50.9 
±12.3 years. Mean BMI of males and females was 30.5kg/m² and 31.7kg/m² respectively. 
The majority of patients had white skin (67.2%) and the rest brown to dark brown skin 
(32.8%). The median calculated sun index pre-operatively and post-operatively was 0.715; 
this can be calculated as 38 minutes sun exposure three times per week on arms and 
legs. Vitamin D oral intake from food was 195IU/day, and with supplementation added, 
202IU/day. More than 65% of the population had insufficient plasma vitamin D status of 
which 29.9% were deficient with a mean value of 26ng/mL(SD 9.6).Correlation of vitamin 
D status with gender, smoking, vitamin D oral intake and BMI was not statistically 
significant. There was a weak positive correlation (r=0.249) between age and vitamin D 
status. There was a significant difference in vitamin D status of white and brown skin tones 
(9.82ng/mL)(p=0.025). There was a moderate positive correlation between vitamin D 
status and calculated sun index (r=0.451)(p=0.017). Sun exposure can be seen as a 
positive predictive indicator of vitamin D status where a calculated sun index of 1.159 yield 
a sensitivity of 68.2% and specificity of 56.5% (p=0.054). There was no statistical 
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significant change in sun exposure, vitamin D intake and vitamin D status after surgical 
intervention. 
 
Conclusion: Even with sun exposure higher than the current recommendation, 25(OH)D 
levels were still very low; thus it can be suggested that the current recommendation for sun 
exposure might need to be doubled to achieve sufficient levels of 25(OH)D. Minor 
orthopaedic surgical interventions do not negatively influence sun exposure habits, vitamin 
D intake and thus vitamin D status, but these patients might be considered to be an “at 































Inleiding: Vitamien D is 'n vetoplosbare vitamien, geklassifiseer as 9,10-secosteroid 
hormoon voorloper. Huidige navorsing het aan die lig gebring dat optimale vitamien D 
status noodsaaklik is vir 'n verskeidenheid van skeletale en nie-skeletale uitkomste. 
Vitamien D status word gedefinieer as voldoende (>30ng/ml), onvoldoende (20–30ng/ml) 
en gebrekkig (<20ng/ml) vir die doel van hierdie studie. Data oor 25(OH)D in Suid-Afrika is 
beperk en status van volwasse ortopediese pre-operatiewe pasiënte nog nie bepaal nie. 
Hierdie studie het ten doel gehad om die vitamien D status van ortopediese chirurgie 
pasiënte te bepaal, die impak van die chirurgiese ingreep op vitamien D status ná 
intervensie asook die verhouding tussen vitamien D status en demografiese parameters, 
antropometrie, son blootstelling en vitamien D inname   
 
Metodes: Gedurende die studietydperk (April 2014–September 2014) was pasiënte 
geïdentifiseer vanaf die ortopediese chirurgiese lyste by Mulbarton hospitaal in 
Johannesburg. Pre-operatiewe antropometriese metings en relevante vraelyste 
(demografies, vel klassifikasie, sonblootstelling (berekende sonindeks) en ‘n voedsel 
vraelys vir vitamien D) is voltooi. Biochemiese ontleding van vitamien D is pre-operatief 
gedoen. Met die opvolg besoek is vitamien D status, sonblootstelling en vitamien D 
voedsel vraelys herhaal.       
 
Resultate: 'n Totaal van 67 pasiënte (67.2% vroue) was ingesluit. Gemiddelde ouderdom 
was 50.9 ±12.3 jaar. Gemiddelde liggaamsmassa-indeks (LMI) van mans en vrouens was 
30.5kg/m² en 31.7kg/m² onderskeidelik. Die meerderheid van pasiënte het ‘n  wit  (67.2%) 
en die res ‘n bruin tot donkerbruin velkeur (32.8%) gehad. Die mediaan berekende 
sonindeks  pre-operatief en post-operatief was 0.715; dit kan bereken word as 38 minute 
sonblootstelling drie keer per week op arms en bene. Gemiddelde orale inname van 
vitamien D  vanaf voedsel was 195IU/dag, en met aanvullings 202IU/dag. Meer as 65% 
van die studiegroep het onvoldoende plasma vitamien D status gehad waarvan 29.9% 
gebrekkig was met 'n gemiddelde waarde van 26ng/ml(SD 9.6). Korrelasie tussen vitamien 
D status en geslag, rook gewoontes, orale vitamien D  inname en LMI was nie statisties 
betekenisvol nie. Daar was 'n swak positiewe korrelasie (r=0.249) tussen ouderdom en 
vitamien D status. Daar was 'n beduidende verskil in 25(OH)D van respondente met ‘n wit 
en bruin velkleur (9.82ng/ml)(p=0.025). Daar was 'n matige positiewe korrelasie tussen 
25(OH)D en berekende sonindeks (r=0.451) (p=0.017). Sonblootstelling kan gesien word 
as 'n positiewe  aanwyser van vitamien D status. 'n Berekende sonindeks van 1.159 lewer 
Stellenbosch University  https://scholar.sun.ac.za
vi 
 
‘n sensitiwiteit van  68.2% en ‘n spesifisiteit van 56.5% (p=0.054) as ‘n aanwyser van 
voldoende vitamien D status. Daar was geen statisties beduidende verandering in 
sonblootstelling, vitamien D inname en vitamien D status na die chirurgiese ingryping nie.  
 
Gevolgtrekking: Selfs met sonblootstelling  hoër as die huidige kliniese  aanbeveling, was 
vitamien D vlakke van hierdie populasie steeds  baie laag. Daar kan voorgestel word dat 
die huidige aanbeveling vir sonblootstelling verdubbel word om voldoende vitamien D 
status te bewerkstellig. Klein ortopediese chirurgiese ingrepe beinvloed nie 
sonblootstelling, vitamien D inname en dus vitamien D status post-operatief negatief nie. 
Hierdie pasiënte kan as ‘n "risiko" groep oorweeg word  as gevolg van  hul gemiddelde 
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LIST OF DEFINITIONS 
Vitamin D: A fat-soluble vitamin chemically related to the steroids and essential for the 
normal formation of bones and teeth and for the absorption of calcium and phosphorus 
from the GI tract. Ultraviolet rays activate a form of cholesterol in an oil of the skin that is 
converted to a form of the vitamin in the kidney.1 
 
Vitamin D2 (Ergocalciferol): A fat-soluble, crystalline unsaturated alcohol produced by 
ultraviolet irradiation of ergosterol in plants. It is used as a dietary supplement in the 
prophylaxis and treatment of rickets, osteomalacia, and other hypocalcaemic disorders. 
Also called  oleovitamin D2.
1 
 
Vitamin D3 (Cholecalciferol): An antirachitic, white, odourless crystalline unsaturated 
alcohol that is the predominant form of vitamin D of animal origin. It is found in most fish-
liver oils, butter, brain, and egg yolk and is formed in the skin, fur, and feathers of animals 
and birds exposed to sunlight or ultraviolet rays. Also called activated 7-
dehydrocholesterol.1 
 
Vitamin deficiency: A state or condition resulting from the lack of or inability to use one or 
more vitamins. The symptoms and manifestations of each deficiency vary, depending on 
the specific function of the vitamin in promoting growth and development and maintaining 
body health.1 
 
25(OH)D: (25-hydroxyvitamin D) also known as calcifediol or calcidiol: a major circulating 
metabolite of vitamin D.1 
 
Ultraviolet: Indicating electromagnetic radiation of wavelength shorter than that of the 
violet end of the spectrum, with wavelengths of 4–400 nm (nanometers). Ultraviolet A 
(UVA) is electromagnetic radiation with wavelengths between 320–400nm, containing over 
99 percent of radiation that reaches the surface of the earth. Ultraviolet B (UVB) is 
electromagnetic radiation with wavelengths between 290–315nm, containing less than 1 
percent of the ultraviolet radiation that reaches the earth's surface. Ultraviolet B causes 
vitamin D production and sunburn.1 





































The tale of the compound, calciferol, is a remarkable but well-known one regarding a 
prohormone that is involved in calcium and phosphorus homeostasis and bone 
mineralisation.2,3,5,6 Vitamin D, also known as the “sunshine vitamin”,7-10 is often taken for 
granted as it is believed to be abundant in a healthy diet and sunny environment.2 In the 
last decade the interest in vitamin D among scientists has escalated significantly as 
scientists have suggested that the effect of vitamin D continues beyond its function in 
healthy bones. There has also been a plethora of research and publications linking vitamin 
D insufficiency and deficiency with an increasing number of medical conditions.10 Vitamin 
D relates to both ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3). 
Cholecalciferol is more biologically active and the preferred form of vitamin D, but both are 
used in nutritional supplements and food fortification.11 Only a few foods naturally contain 
vitamin D and in South Africa only a limited number of foods are fortified2 with vitamin D, 
mostly cereal and margarine.12 
 
Vitamin D status varies significantly between different countries in Asia, Europe, the 
Middle East and Africa. This is the result of different degrees of sun exposure, clothing, 
pollution, use of sunscreen, latitude, altitude, season, ethnic group, skin pigmentation,1,7,13 
genetics, body mass index (BMI), age,1 dietary intake, fortification programmes and 
supplementation use.1,13 
 
Vitamin D deficiency is fast being acknowledged as one of the most widespread medical 
conditions in the world.3,9,14,15 Rickets has been described as the “tip of the Vitamin D-
deficiency iceberg”.16 Vitamin D insufficiency and deficiency not only contributes to 
metabolic bone disease in children and in adults, but it may also increase the risk of many 
other common chronic diseases.2 Some of the areas of interest for researchers are 
autoimmune diseases, cardiovascular disease, cancer,2,3 multiple sclerosis, rheumatoid 
arthritis, type I diabetes, and orthopaedic patients, to name but a few.2,16 
 
To the best knowledge of the author, the vitamin D status of South African adult patients in 
private hospitals that had elective orthopaedic surgery has not yet been determined. 
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1.2 History and Current Situation 
From an evolutionary viewpoint, vitamin D was formed from sunlight exposure in 
phytoplankton and zooplankton present in the oceans for more than 500 million 
years.2,17,18 It was suggested very early (1924, 1927) that the vitamin D found in oily fish 
was due to the dietary intake of the vitamin from these plankton. The seasonal variations 
in the vitamin D content of oily fish correlate with higher sun exposure in summer and 
lower exposure in winter months.17 
 
In terms of human history, the very beginning of the industrial revolution in Northern 
Europe was where the vitamin D deficiency epidemic originated.2,17,19 People began 
gathering together in cities and lived in dwellings that were built very close to one another. 
Burning of wood and coal caused air pollution and children living in these developed areas 
had very little direct exposure to sun.2,17 The first clinical description was in 1651 by 
Glisson, De Boot and Whistler, describing children with rickets (growth retardation and 
skeletal deformities, including rachitic rosary (bony projections along the rib cage) and 
either knock knees or bow legs).2,19 The disease migrated to the northern United States 
(New York and Boston), and to Leiden in the Netherlands. By the 1900s, rickets was so 
devastating and widespread that approximately 80–90% of children suffered from the 
disease. The first Caesarean section under modern antiseptic conditions (1888) was 
performed in Glasgow by Murdoch Cameron (31 March 1847–28 April 1930) to assist a 
young rachitic woman (Catherine Colquhoun) in birthing because the baby could not be 
delivered naturally owing to her deformed, flattened pelvis.20 In such rachitic women, 
birthing by Caesarean section became very common.17 The seldom-used procedure that 
usually culminated in the death of the mother became a safe and routine operation under 
antiseptic conditions.20 
 
The first recognised association between sunshine and rickets was made in the beginning 
of the 19th century in 1822 by Jęrdrezej Śniadecki (1768–1838).6 He published his clinical 
annotations of children living in the inner city in Warsaw with a high occurrence of the 
disease versus the children in the rural areas outside Warsaw that did not have the 
disease. This was followed by observations by Palm about children living in industrialised 
cities in Great Britain that were at high risk of developing rickets. His colleagues from 
China and India wrote that malnourished children in these countries that lived in squalor 
were actually free of this disease. Palm came to the conclusion that sunbathing could 
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prevent rickets and that a type of sunshine recorder needed to be developed to measure 
the bone-healing properties of the sun. This fell on deaf ears until 1919, when 
Huldschinsky reported that exposure to ultraviolet radiation from a mercury arc lamp 
resulted in the cure of rickets.2,3,17-19 Hess and Unger (1921) noted effective treatment for 
rickets when children were exposed to sunlight over a period of several months on the roof 
of a hospital in New York.1 Between 1922 and 1924, Hess and Weinstock21 and 
Steenbock and Black22 published data in The Journal of Biological Chemistry about 
irradiating a wide variety of substances such as vegetable oils and grasses. They reported 
that the irradiation process gave anti-rachitic activity to these foods. It was also shown that 
sun exposure prevented rickets in rats. At about the same time Elmer V McCollum at the 
University of Wisconsin and later at Johns Hopkins University designed an ingenious 
series of experiments where he destroyed the vitamin A in cod liver oil and identified the 
remaining separate antirachitic substance. In the 1922 publication of these experiments, 
the designation of vitamins in alphabetic order was followed and vitamin D was named, as 
vitamin B and C had been recently named.23 Steenbock and Black, and Hess and 
Weinstock, as two independent research groups, experimented on irradiation of skin and 
introduced the model that the irradiation of food with ultraviolet (UV) radiation would 
prevent and treat rickets, to a large extent the same as cod liver oil did. This ultimately led 
to the fortification of milk and other products, and this fortification process in essence 
eradicated rickets.2,17,23 Fortification with vitamin D became so popular in the 1930s and 
1940s that peanut butter, bread, hot dogs and soda were fortified. Schlitz Brewery 
introduced fortified beer2,17 and marketed it as beer with “sunny energy in both summer 
and winter”.2 
 
By 1925 Adolf Windhaus from Germany was considered the leading expert in sterol 
research. He was awarded the Nobel Prize for Chemistry in 1928. In partnership with other 
scientists, such as Hess and Rosenheim, the teams deduced that ergosterol was the 
probable parent substance of vitamin D that was found in food. Later, back in Germany, 
Windhaus isolated three forms of vitamin D and called them D1 and D2 (from plant sterols) 
and D3 (from irradiated skin).
23 The British team of scientists led by FA Askew successfully 
defined the chemical makeup of D2 in 1931; this is the form of vitamin D found in irradiated 
food (now called ergocalciferol). Only five years later in 1936 the molecule 7-
dehydrocholesterol was synthesised and then converted through irradiation to D3 (now 
known as cholecalciferol) by Windhaus.10,23 Over the next 40 years research teams tried to 
map the metabolic pathway of vitamin D. Scientists did not possess all the tools until the 
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1960s, when new techniques using radioactive-labelled substances emerged. Between 
1968 and 1971 great progress was made in the metabolic processing of vitamin D. In 1968 
the team of DeLuca isolated an active vitamin D metabolite that was identified as 25-
hydroxyvitamin D3 and later demonstrated to be produced in the liver. During the next two 
years it was shown that there was a second metabolite produced in the kidney. In 1971 
three research groups published papers reporting the chemical structure of this metabolite 
that was identified as 1.25-dihydroxyvitamin D3. It was also around this time that the link 
with calcium metabolism was finally established.10 In the 1980s, evidence was found by 
several groups of researchers that vitamin D was present in other cells that were not part 
of calcium metabolism, such as brain, lymphocytes, skin and malignant tissues. The 
immunosuppressant function of vitamin D was used in research on autoimmune disease. 
In 1994 the US Food and Drug Administration approved a topical calcitriol treatment for 
psoriasis.10,23 Now as we are entering the twenty-first century, researchers will keep on 
pursuing new applications for vitamin D while remembering the important role it plays in 
bone health.23 
 
1.3 Definition of Vitamin D Status 
The Endocrine Society is the largest global membership organisation that represents 
professionals from the field of endocrinology. The society has members from 122 
countries, with its headquarters in Washington DC.77 On March 15, 2016, the Institute of 
Medicine (IOM), a division of the National Academies of Sciences, Engineering, and 
Medicine (the National Academies) that focuses on health and medicine, was renamed the 
Health and Medicine Division (HMD). The National Academies are private, non-profit 
American institutions that provide independent, objective analysis and advice related to 
science, technology and medicine.78 Note that all reports issued by the new HMD division 
will be cited as reports of the National Academies of Sciences, Engineering, and Medicine. 
Reports issued prior to June 30, 2015 will continue to be cited as IOM reports in 
perpetuity.78 
 
The reference values for the different categories of vitamin D status are indicated in Table 
1.2. It should be noted that there are two schools of thought in defining vitamin D status; 
first there is the Institute of Medicine (IOM) 2011 report on dietary intakes for calcium and 
Vitamin D,79,80 and secondly the Endocrine Society Clinical Practice Guidelines on 
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Evaluation, Treatment, and Prevention of Vitamin D Deficiency.37 To date (2016) the IOM 
has not released newer guidelines.80 
 
The objective of the Endocrine Society Clinical Practice Guidelines on Evaluation, 
Treatment, and Prevention of Vitamin D Deficiency is “to provide guidelines to clinicians for 
the evaluation, treatment, and prevention of vitamin D deficiency with an emphasis on the 
care of patients who are at risk for deficiency”.37,81 The IOM Committee, focused on a 
healthier population, concluded “that available scientific evidence supports a key role of 
calcium and vitamin D in skeletal health, consistent with a cause-and-effect relationship 
and providing a sound basis for determination of intake requirements”.79,81 The IOM 
concluded that after careful deliberation the evidence showed that bone health was the 
only outcome that satisfied the criteria for vitamin D recommendations as an “indicator” for 
healthy skeletal outcomes.37 
 
There are several main positions of discrepancy between the two published 
recommendations. The first main point is the sufficient vitamin D level; IOM states 
>20ng/mL (>50nmol/L).18,79,80,82,83 and the Endocrine Society recommends levels of 
>30ng/mL (>75nmol/L).18,37,82,84 The IOM also concluded that evidence was inconsistent 
and inconclusive regarding nonskeletal benefits and that no recommendations could be 
made in this regard.79,80 The Endocrine Society takes a more futuristic view in stating that 
“recommendations will likely need to be revised as future evidence accumulates”.37 
 
The 2016 report on vitamin D and health of the Scientific Advisory Committee on Nutrition 
(SACN) states that the United Kingdom (UK) currently defines the lower limit of adequacy 
at 10ng/mL (25nmol/L) based on the increased risk of osteomalacia and rickets at 
concentrations below this level.85 It is recommended by SACN that the serum 25(OH)D 
levels of all individuals in the UK should not fall below 10ng/mL (25nmol/L) at any time of 
the year.85 The SACN advises on nutrition and related matters to Public Health England 
and other UK government organisations. 
 
In a recent editorial in The New England Journal of Medicine Manson et al warns against 
the misapplication and misinterpretation of the IOM reference values of vitamin D as such 
misunderstandings can lead to unnecessary vitamin D screening and supplementation that 
can lead to mounting health costs. Clinical judgement and individualized interventions is 
recommended to avoid overscreening and overprescribing of vitamin D supplements.137 
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Reid concludes in a recent published article that individuals should not have 25(OH)D 
levels under 16ng/mL since such a strategy would prevent osteomalacia, a condition 
usually seen with levels under 10ng/mL. The author adds that osteomalacia and rickets 
are the only conditions where abundant clinical evidence is available with not enough 
conclusive trial evidence of other beneficial effects of vitamin D.138  
 
Table 1.1: Definition of Vitamin D Status  
Vitamin D Status Plasma Concentrations 
Endocrine Society IOM SACN 






























 >150 >374 >50 >125   
1ng/mL = 2.5nmol/L 
IOM – Institute of Medicine 
SACN - Scientific Advisory Committee on Nutrition 
* Should cover ≥ 97.5% of the population                                                                                                           
#
 Should cover approximately half the population 
 
There are two motivations for positioning the sufficient range for 25(OH)D at >30 ng/mL: 
one proposes that levels of PTH increase when plasma levels of 25(OH)D fall beneath    
30ng/mL16,34,37 and the other proposes that active calcium absorption is best when the 
level of 25(OH)D is 30ng/mL.34,37 Whereas secondary hyperparathyroidism can be 
prevented with 25(OH)D levels of at least 20ng/mL,86 25(OH)D should most likely be at 
least 30ng/mL to maximise cellular health2,3,14,6,24,34,35,86 and uphold skeletal health.37 
Levels of at least 30ng/mL are necessary to start antifracture effectiveness.37 Jesudason et 
al. concluded in their study on the relationship between serum  25(OH)D levels and bone 
resorption markers (hydroxyproline, pyridinoline and deoxypyridinoline) that these bone 
resorption markers can be detected when 25(OH)D levels fall beneath 24ng/mL; thus 
levels above 24ng/mL may be required for optimum bone health.55 
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1.4 Prevalence of Vitamin D Deficiency 
Vitamin D status in various European countries, North America, Asia and Oceania has 
been assessed in numerous studies and in great detail.13,16,18,24-26  In the analysis done by 
Wahl et al. on the global representation of vitamin D status, 200 studies from 46 countries 
were scrutinised and of these, 46 were considered representative. The largest number of 
studies came out of Europe (48%), followed by North America (27%) and Asia-Pacific 
(16.5%). These results were then summarised in a world map with colour coding that gives 
a snapshot of 25-hydroxyvitamin D (25(OH)D) levels around the globe (Figure 1.1).26 The 
global prevalence of vitamin D deficiency and insufficiency varies from 3%–91%, but the 
interpretation of the data from different studies is hindered by the large variation in cut-off 
points used to define deficiency and insufficiency that can range from 5ng/mL to 
30ng/mL.10,18 
 
Adult vitamin D status studies in Africa27 and specifically South Africa are few and far 
between – A study done in 1975 on elderly South African patients with hip fractures found 
mean serum 25(OH)D concentrations at 17.7ng/mL, SD 9.2ng/mL.121 One study on black 
South African woman (n=43) after delivery of their babies done in 1987 in the Transkei 
found normal serum 25(OH)D levels of 32.7ng/mL.121 A study done on vitamin D status of 
10-year-old urban South African children (2011) concluded that the vitamin D status of the 
children was generally good, with only 7% deficient;28 another study on vitamin D 
formation by sunlight in Johannesburg concluded that the seasonal variation in 25(OH)D 
was a consequence of increased clothing and less time spent outdoors during winter, 
rather than less UV radiation reaching the earth as  seasonal changes in in vitro 
production were not found.29 Haarburger et al. found in 2009 that the median value of their 
study population (age 2–64) was 19.3ng/mL (range 2.2–42.4ng/mL). Vitamin D deficiency, 
here defined as <18ng/mL, was found in 41% of subjects.30 In a recent (2015) review of 
South African studies (25 studies) assessing 25(OH)D it was found that whites had the 
highest 25(OH)D (34.4ng/mL), followed by blacks (28.4ng/mL), mixed ancestry 
(20.4ng/mL) and Asian Indians (16ng/mL). According to this data it is apparent that in 
South Africa, Asian-Indians are vitamin D deficient, while blacks possibly have insufficient 
and whites sufficient vitamin D.121 Results indicate that population groups in South Africa 
with moderate to dark skin pigmentation are at high risk of deficiency when UVB radiation 
is limited owing to seasonal fluctuations.122 
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A recent study done in Israel, an area characterised by mostly sunny year-round weather, 
revealed Vitamin D deficiency to be prevalent. In this study, 78% of subjects had 




>30ng/mL               20-29.9ng/mL               10-19.9ng/mL               <10ng/mL 
Permission to use the figure was obtained from the author (2015, October 15). 




1.5 Metabolism of Vitamin D 
Vitamin D is a fat-soluble vitamin,31 but not a true vitamin (a substance that our body 
cannot manufacture and can only be obtained from dietary sources).23 Vitamin D is 
correctly classified as a 9,10-secosteroid hormone precursor.7,23,32 Vitamin D is a 
secosteroid hormone because one of the rings of its structure has a broken carbon-
carbonbond (this occurs in the 9,10 carbon-carbon bond).32 A hormone can be described 
as a chemical substance that is produced in one organ and then transported to the target 
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organ. Vitamin D is naturally present in only a few foods, added to some food and 
available as a dietary supplement. Vitamin D is also produced endogenously when skin is 
exposed to ultraviolet rays from sunlight.31 Vitamin D refers to ergocalciferol (vitamin D2) 
and cholecalciferol (vitamin D3)
11 (Figure 1.2).18,32 When exposed to solar ultraviolet B 
radiation (UVB, 290-315nm),6,9,17,33 7-dehydrocholesterol (7-DHC) in the skin absorbs the 
UVB radiation and is transformed to pre-vitamin D3, which is immediately transformed to 
vitamin D3 in a heat-dependent process.
2,6,9,11,33-35 During the conversion process, vitamin 
D3 is expelled from the plasma membrane into the extracellular space. The vitamin D 
binding protein in the dermal capillary bed has an affinity for D3 and pulls it into circulation.  
 
         Vitamin D2 (Ergocalciferol)   Vitamin D3 (Cholecalciferol) 
 
Figure 1.2: Chemical Structure of Vitamin D2 and Vitamin D3
18 
 
Vitamin D from dietary sources is bound to the vitamin D binding protein (DBP),6,34 taken 
up by enterocytes and packaged into chylomicron remnants that enter the bloodstream via 
the lymphatic system8 and transported to the liver or fat for storage. In the liver it is 
transformed to 25-hydroxyvitamin D (25(OH)D), its main circulating form. In this structure it 
has restricted biological activity. In the kidney 25(OH)D is converted to its most active 
circulating metabolite, 1.25-hydroxyvitamin D (1,25(OH)2D) by the enzyme CYP27B1 
under the influence of parathyroid hormone (PTH)2,6,16,18,34 and a multitude of other factors, 
including serum phosphorus, calcium and fibroblast growth factor 23 (FGF-23).18 
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CYP27B1 is also expressed extrarenally in a large number of tissues, including bone, 
prostate,  placenta, T-lymphocytes, keratinocytes, macrophages, dentritic cells, several 
cancer cells and the parathyroid gland, and this enables the production of 1,25(OH)2D.
18 
The prime action of 1,25(OH)2D is maintaining calcium and phosphorus homeostasis and 
bone health;6,11 this happens through the vitamin D receptor to improve intestinal calcium 
absorption and to encourage the maturation of osteoclasts6 (Figure 1.3).36 
 
In spite of this it has been progressively acknowledged that vitamin D has pleiotropic 
effects on an array of extraskeletal tissues, suggesting a vital role in disease prevention 
and health.6 
 
Sun exposure over extended periods does not result in excess production of vitamin D3 
and thus intoxication, as the previtamin D3 that is produced and the thermal isomerisation 
product - vitamin D3 - does not get absorbed into the circulation and will absorb solar UV 
radiation and isomerise to numerous photoproducts that are believed to have little action 
on calcium metabolism.2 
 
Anything that influences the number of solar UVB photons that infiltrate the skin or 
changes the amount of 7-DHC in the skin will influence the cutaneous production of 
vitamin D3. The level of 7-DHC in the epidermis is reasonably constant until in later life, 
when it begins to decline. A person 70 years of age exposed to the same quantity of 
sunlight as a 20-year-old will produce approximately 25% of the vitamin D3 that the 20-



















     
 
 
















1.6 Sources of Vitamin D 
The sources of vitamin D include oral intake (from diet and/or supplements in the form of 
cholechalciferol [D3] or ergocalciferol [D2]) (Figure 1.2) and cutaneous synthesis from 
sunlight (in the form of cholechalciferol [D3]).
6,9,17,19,24,33 Vitamin D supplements are 
covered in more detail in Section 1.12. 
 
Vitamin D occurs naturally in very few foods (Table 1.1). Food sources of vitamin D are 
oily fish such as sardines (291 IU/100g), salmon (528 IU/100g), herring (1000 IU/100g) 
and kipper (1000 IU/100g), egg yolk (162 IU/egg) and cod liver oil (500 IU/ ml). In South 
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Africa, food sources that contain vitamin D are more limited than in other northern 
hemisphere countries. For example, irradiated mushrooms are a good source of vitamin 
D,2,11 but in South Africa mushrooms are not exposed to UV light and contain no vitamin 
D.12 Very few food items in South Africa are fortified with vitamin D; only certain cereals 
like Kellogg’s® (e.g. Special K, Rice Crispies, Frosties, Corn Flakes and All Bran) (28 
IU/25g) and FUTURELIFE® (300 IU/50g) are fortified; most other cereals contain no 
vitamin D.12 According to the Medical Research Council of South Africa food composition 
tables, margarine contains between 10–12 IU/5g, depending on the brand used. Health 
bars like PVM Energy® bars contain 209 IU per bar and milk powders contain 100 
IU/25g.12  When comparing these figures with the recommended dietary allowance (RDA) 
of vitamin D for adults of the Institute of Medicine (IOM) of 600 IU/day,32 it can be noted 
that very few foods make a considerable contribution to the daily vitamin D intake. 
FUTURELIFE® contains 50% of the RDA and Kellogg’s® cereals only 5%.  
 
Humans have evolved to derive most of their vitamin D requirements from cutaneous 
synthesis. Most people will get more that 90% of their vitamin D requirements from casual 
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Table 1.2:  Dietary Sources of Vitamin D in South Africa 




Butterfish, grilled 100g 25.94 1037 
Herring, grilled 100g 25.94 1037 
Kipper, baked (smoked herring) 100g 25.00 1000 
Salmon, canned, drained 100g 13.21 528 
Cod liver oil 5ml 12.50 500 
Pilchards, canned in brine / tomato sauce 100g 8.00 320 
Tuna, canned in oil, drained 100g 7.40 296 
Sardines, canned in oil, drained 100g 7.28 291 
Sardines, canned in tomato sauce, drained 100g 6.79 271 
Egg, whole (vitamin D in yolk) 51g 4.05 162 
Liver, chicken 100g 1.79 72 
Liver, beef 100g 1.55 62 
Veal, cooked 100g 1.50 60 
Pork, cooked 100g 1.00 40 
Beef, cooked 100g 0.65 26 
Fortified Foods
12,38 
   
Health Bar PVM
®
 55g 5.23 290 
Milk powder 25g      






 40g 0.9 36 
Margarine 14g 0.70 28 




1.7 Vitamin D Status Assessment 
Plasma 25-hydroxyvitamin D (25(OH)D) concentration is the parameter of choice for 
assessing vitamin D status because of its long half-life (approximately 2–3 
weeks).13,15,24,33,44 The whole-body half-life of radio-labelled vitamin D is approximately 2 
months.45 Seamans and Cashman concluded in their systematic review of 36 randomised 
control trials (RCTs) and four before/after studies, that circulating 25(OH)D is a reliable 
and robust marker of vitamin D status.46  
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Although 1,25 dihydroxyvitamin D (1,25(OH)2D) is the biological active form of vitamin D, it 
is not considered appropriate to assess vitamin D status for various reasons. The half-life 
of circulating 1,25(OH)2D is very short
2,6,30 (4–6 hours),3,9 the circulating levels of 
1,25(OH)2D are a thousand-fold lower than those of 25(OH)D, and as a person becomes 
vitamin D deficient, there is diminished intestinal calcium absorption which will lower the 
ionised calcium momentarily. In the short term this signal is then recognised by the 
calcium sensor in the parathyroid glands to boost the secretion and production of 
parathyroid hormone (PTH) (secondary hyperparathyroidism). PTH regulates calcium 
metabolism by escalating reabsorption of calcium in the kidney, escalating mobilisation of 
calcium from the skeleton and escalating the production of 1,25(OH)2D. This means that 
as a person becomes vitamin D insufficient and later deficient in the long term, the 
elevated levels of PTH result in normal to increased levels of 1,25(OH)2D. This mechanism 
makes the measuring of 1,25(OH)2D inappropriate as an indicator of vitamin D status.
2,6 
 
Long-term vitamin D status is thus not reflected by 1,25(OH)2D levels. The measurement 
of 1,25(OH)2D can however be used effectively in the diagnosis of certain acquired and 
inherited disorders in calcium metabolism as it relates to the alteration in the extra renal or 
renal production of 1,25(OH)2D.
3 
 
Radioimmunoassay is the most widely used method to measure 25(OH)D.6,44 Automated 
direct detection methods such as high-performance liquid chromatography, 
chemiluminescence and liquid chromatography–mass spectroscopy assay have become 
more popular, especially in large medical centres.6 Automated, antibody- and 
microparticle-based  chemiluminescent immunoassay methods using the LIAISON® 25 OH 
vitamin D assay and Abbott Architect assay have been clinically validated as accurate, 
rapid and precise tools in the measuring of 25(OH)D.42,47 A number of authors point to the 
strengths of immunoassays running on automated platforms in terms of high output and 
convenience, especially for laboratories analysing large numbers of samples.42,47 The 
measurement of 25(OH)D by immunoassay would remain the method of choice for 
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Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is seen as the gold 
standard of testing. The LC-MS/MS method has seen huge growth during the last 10–15 
years. The method offers analytical specificity superior to that of the immunoassays or 
conventional high-performance/pressure liquid chromatography (HPLC), but sample 
throughput lags behind automated immunoassays.48 
 
In a recent (2015) pilot study done by Vignali et al., work was done on the development of 
an algorithm to estimate individual vitamin D status, independently of serum 25(OH)D, 
using a simple questionnaire. The questionnaire mostly relied on indirect measurement of 
sunlight exposure. The algorithm performed extremely well with 212 of 235 (90.2%) of 
subjects assigned to the correct vitamin D status class. Four classes of vitamin D status 
were assumed: ≤10, 10–19.9, 20–29.9 and ≥30ng/mL. A larger study is planned with more 
varied population groups, different seasons, latitudes and urban and rural communities. 
This method might help select subjects that need serum 25(OH)D measurement.49  
 
 
1.8 Functions of Vitamin D 
1.8.1 Skeletal functions of vitamin D 
The main and most recognised function of vitamin D is to maintain calcium and 
phosphorus homeostasis and to support bone mineralisation.11,15,34,50 This is accomplished 
by increased calcium absorption in the intestinal tract, bone and kidney.2,7,8,16 The small 
intestine is where dietary calcium will be absorbed and bone serves as a huge reservoir of 
calcium. Stimulating net resorption of bone minerals releases calcium and phosphate into 
the blood, and suppressing this effect allows calcium to be deposited in the bone. The 
kidney is vitally important in calcium homeostasis. Within normal blood calcium levels, 
almost all of the calcium that enters kidney glomerular filtrate is reabsorbed into blood, 
which will preserve blood calcium levels. If tubular reabsorption of calcium slows down, 
calcium will be by excreted into the urine.16 
 
In a vitamin D-deficient state, the intestinal absorption of dietary calcium will be 
approximately 10–15% and in a vitamin D-efficient state, absorption will be approximately 
30–40%. With increased demand, during periods of growth, pregnancy and lactation, as 
much as 60–80% can be absorbed.2,7,9,16,18 On the other hand, if there is not enough 
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dietary calcium, 1,25(OH)2D will interact with the vitamin D receptor (VDR) in the 
osteoblast in the bone which will ultimately lead to the mobilising of calcium stores from 
the skeleton to sustain serum calcium levels within the normal range.7,8 The production of 
1,25(OH)2D is stimulated by parathyroid hormone (PTH). There is a negative response 
through calcium which reduces PTH and a direct negative response from 1,25(OH)2D to 
PTH. The functioning metabolite 1,25(OH)2D also shows swift actions through a 
membrane receptor.19 1,25(OH)2D can aggressively enhance dietary phosphorus 
absorption. When phosphate and calcium are in a supersaturated state, it will result in 
mineralisation of the collagen matrix laid down by osteoblast. Although 1,25(OH)2D does 
not have a direct active role in mineralisation, it is responsible for maintaining blood levels 
of phosphorus and calcium within the normal range so that mineralisation can take place.7 
 
In adults low levels of 25(OH)D and high PTH lead to low calcium and phosphorus 
product, with consequential osteomalacia (derived from Greek, osteo, which means “bone” 
and malacia which means “softness”) which is a defective mineralisation of the collagen 
matrix, bringing about a reduction of structural support; it is also associated with an 
increased risk of fracture.18 With the decline in 25(OH)D levels leading to secondary 
hyperparathyroidism associated with osteoclastogenesis (the development of osteoclast) 
and a subsequent  increase in bone resorption that exceeds osteoblast-mediated bone 
formation, this can hasten and aggravate osteopenia and osteoporosis in adults. Vitamin D 
supports bone health by upholding the PTH levels at a physiologically healthy level, 
stimulating osteoblastic action and bone mineralisation, plus reducing risks of falls and in 
that way reducing the risk of fracture.18 This effect seems to be mediated by improved 
muscle function and strength.9,51 
 
Eight studies were included in the meta-analysis by Bischoff-Ferrari et al. on fall prevention 
and vitamin D supplementation. They concluded that vitamin D‘s effects are not limited to 
bone health alone. “Stronger bones are less likely to fracture”, as vitamin D 
supplementation (700 – 1000 IU/day) reduces the risk of falling amongst older individuals 
by 19%.52 In addition to the role that vitamin D plays in promoting healthy bones and bone 
growth, it has also been established to reduce the risk of stress fractures in young female 
military recruits as this group may be especially vulnerable to stress fractures owing to 
their intense physical activity. Stress fractures can be reduced by 20% by supplementing 
with calcium (2000mg) and vitamin D (800 IU).53 
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The incidence of osteoporosis among the elderly is between 33–66%, depending on their 
age.16 It is estimated that the lifetime risk of an osteoporotic fracture is 50% for women and 
20% for men 50 years or older in their remaining lifetime.26 Studies report a reduction of up 
to 52% of hip fractures with calcium (1200mg) and vitamin D (800 IU) 
supplementation.9,16,35 It is documented that 52% of woman taking osteoporotic 
medications have vitamin D insufficiency (<30ng/mL). All osteoporotic patients taking 
osteoporosis medications need sufficient vitamin D and calcium to take full advantage of 
the benefits of these drugs.9 
 
 
1.8.1.1 Vitamin D and fracture healing 
Fracture healing can be divided into four stages that overlap: the inflammation stage (week 
1), the soft callus-formation stage (week 2–3), the hard callus-formation stage (week 4–
16), and the bone-remodeling stage (week 16 and beyond).36 Each of these stages is 
characterised by specific complex cellular and molecular processes. Vitamin D has a role 
to play in every stage of fracture healing.36 
 
Amongst older adults, it is recorded that about 30% fall each year and of these falls about 
10% result in a fracture. These falls are a significant factor in morbidity and mortality in the 
elderly population.11 According to the National Osteoporosis Foundation of America, about 
24% of individuals aged 50 years and older with hip fractures die in the year after the 
fracture and about 20% of those individuals that were mobile preceding the hip fracture will 
now need long-term care. There was a significant reduction in hip fractures in those 
participants who received vitamin D and calcium supplementation (8 trials with >46 000 
participants; RR=0.84; 95% CI: 0.73–0.96).11 Vitamin D deficiency (36%) and insufficiency 
(78%) have been identified in fragility fracture patients. Lower vitamin D levels are 
associated with an increased risk of falling, diminished muscle strength,54 low bone 
density, hip fractures and increased urine secretion of CrossLaps, a bone resorption 
marker.55 Human bone turnover is a balanced process of bone formation and resorption. 
Most of the organic matrix of bone consists of Type I collagen. This is a helical protein that 
is cross-linked at the C- and N-terminal ends of the molecule. A fragment of collagen at the 
C-terminal end changes its nature; this fragment is called Beta-CTx (Beta–Crosslaps).  
During bone resorption proteases degrade collagen and this fragment is released in 
circulation. In bone resorption this marker is increased.55 
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These results confirm the importance of vitamin D screening and vitamin D 
supplementation guidelines for hospital fracture care pathways. The pathway recommends 
that orthopaedic surgeons prescribe 50 000 IU vitamin D on admission and on discharge 
the following: calcium carbonate (600mg), vitamin D (400 IU), and a multivitamin 
containing 400 IU vitamin D daily.54 
 
Doetsch et al. demonstrated in a double-blind prospective study that vitamin D3 (800 IU) 
and calcium (1000mg) supplementation (12 weeks) versus a placebo can have a positive 
effect (p=0.006) on the healing of a proximal humerus fracture (PHF) (top of the upper arm 
bone) as measured with bone mineral density (BMD) scanning.56 
 
Numerous studies have shown that supplementation of calcium (500mg–1200mg/day) and 
vitamin D (400 IU–800 IU/day) reduces the risk of hip fracture by 26–58% and non-
vertebral fracture incidence by 23 –32%.9,52 There have been questions on the efficacy of 
calcium and vitamin D to reduce fracture risk; however on closer investigation it was found 
that subjects in the study were less than 60% compliant in taking their supplementation 
versus the Women’s Health Initiative (WHI) (1000mg calcium and 400 IU Vitamin D) study 
where it was found that women who took their supplementation a minimum of 80% of the 
time had a 29% reduction in hip fractures. It was also noted that 400 IU is a far smaller 
dose (only 40%) than what is now recommended to maintain 25(OH)D levels of 
>30ng/mL.9 
 
Approximately 5–10% of patients will have a certain amount of trouble with the final union 
of their fractures of which the most problematical is nonunion (“normal biological healing 
process ceases to the extent that solid bony union will not occur without further 
treatment”).58 Vitamin D deficiency has been shown to be linked with impaired fracture 
healing. Intestinal calcium absorption that is sub-optimal and increases bone resorption 
can occur with vitamin D deficiency; this deprives the fracture site of the necessary 
calcium it needs for mineralisation. This can play a part in the development of nonunion.58 
The diagnosis and treatment of vitamin D deficiency in nonunion of fractures is important 
owing to the role it plays in bone metabolism.58,59 
 
A recent systematic review of the literature by Gorter et al. provides evidence that vitamin 
D affects the course of fracture healing, but the precise cellular role remains 
uncertain.They found a quantifiable positive effect in the form of improved bone mineral 
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density and improved fracture callus area at the fracture site. It is recommended that future 
research ought to focus on the clinical effects of vitamin D deficiency and the role of 
vitamin D supplementation on fracture healing.36 Eschle and Aeschlimann also ask the 
question if vitamin D supplementation can benefit fracture healing and not only prevent 
fractures. The results of the specific literature search on vitamin D supplementation and 
fracture healing are limited in comparison with research on fracture prevention. The 
conclusion was that the benefits of vitamin D in fracture healing await additional trials, but 
all fractures in the elderly point towards the need for secondary prevention guidelines 
pertaining to falls, osteoporosis and vitamin D.51 This then also begs the question if 
fractures and surgery will influence existing vitamin D status. 
 
 
1.8.1.2 Musculoskeletal function 
Vitamin D deficiency is linked to osteomalacia, in adults presenting with nonspecific 
complaints of melancholy, fatigue, body aches and bone pain, and this can be 
incapacitating to the patient. Symptoms of osteomalacia can be reversed by restoring 
vitamin D status.2,6,16,17 Up to 40–60% of patients with fibromyalgia may have some 
element of osteomalacia and vitamin D deficiency.2,16,17 
 
Vitamin D deficiency is linked to dispersed muscle pain, muscle weakness primarily in the 
proximal muscle groups (muscles closer to the body’s midline), and a decrease in 
performance speed.60 This originates from muscle wasting of mostly type II muscle fibres. 
Secondary hyperparathyroidism and resultant hypophosphatemia in severe vitamin D 
deficiency could also cause proximal muscle weakness. There is a positive association 
between 25(OH)D levels, proximal muscle strength, lower extremity function and physical 
performance. Postural and dynamic balance and muscle strength were increased by 
vitamin D supplementation.18 
 
Several observational studies have reported an association between vitamin D 
insufficiency and poor lower extremity muscle performance, gait imbalance and increased 
risk of falls.6,11,14,16,34,35 The current evidence does not conclude that there is a connection 
between vitamin D and chronic pain. The connection between vitamin D and chronic pain 
would offer a simple solution for the management of chronic pain, but the RCTs are still 
too few and supporting studies are inadequate.61 
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1.8.2 Nonskeletal functions of vitamin D 
The disclosure in 1979 that most body tissues and cells contained vitamin D receptor 
unlocked an exciting new chapter regarding the potential biological functions of vitamin D. 
The vitamin D receptor (VDR) is present in the osteoblast, intestinal tract, lymphocytes, ß-
islet cells and many other organs in the body, including the skin, brain, heart and 
prostate.2,17,35 The local manufacturing of 1,25(OH)2D is considered to be imperative for 
keeping cell growth in check and probably preventing the cell from becoming independent 
and developing into a cancer cell. Activated B and T lymphocytes have VDRs, and 
1,25(OH)2D is a very efficient modulator of the immune function, therefore the link with 
autoimmune diseases.2,16 
 
Optimum vitamin D status may be imperative in a number of non-skeletal functions. 
Vitamin D deficiency may be a factor in glucose intolerance, cardiovascular disease, 
compromised immunity,2,6,15,16,34,50,62 and a range of autoimmune disorders including 
multiple sclerosis, type I diabetes, rheumatoid arthritis, inflammatory bowel disease and 
Behçet’s disease; asthma and cancer; as well as certain psychiatric disorders such as 
depression, schizophrenia and dementia.16,50 
 
The 20 000-person VITAL trial, recently initiated, could help to determine if high doses of 
Vitamin D (2000 IU/day) will reduce the risk of cardiovascular disease (CVD), cancer and 
osteoporosis. At the 17th Workshop on Vitamin D, Chicago, IL, 2014, it was reported that 
VITAL had now completed the recruitment of over 26 000 participants who will be followed 
until 2017. A large portion of these participants will provide blood samples for 25(OH)D 
analyses and there are also 18 supplementary studies with this cohort. It is expected that 
over the next five years, VITAL, together with other large randomised trials of vitamin D 
supplementation worldwide, will provide essential data on the capability of vitamin D 
supplementation to influence disease mitigation in populations.63 Another high dose (4000 
IU/day) vitamin D trial in pre-diabetics is presently in the planning stages. Thus the position 
of vitamin D supplementation in nonskeletal disease must still be fully established.63 
 
The recent systematic review by Bjelakociv et al. suggests that vitamin D (400 IU – 2000 
IU daily) may reduce mortality by about 6%, which corresponds to approximately 200 
individuals needed to be treated for two years for one additional life to be saved. Vitamin D 
also decreases cancer mortality in four per 1000 persons treated for 5–7 years.64 




The evidence for the potential nonskeletal functions and benefits of Vitamin D is not as 
convincing as that for the skeletal effects, and conclusive evidence of these benefits 




When comparing communities living at higher latitudes (with lower UV exposure and thus 
subsequent lower vitamin D status) with communities living at lower latitudes (with higher 
UV exposure and thus subsequent higher vitamin D status), living at higher latitudes is 
associated with a higher risk of the incidence of a variety of cancers.18 Figure 1.466 is a 
graphic representation of all cancer death rates per 100 000. Countries closer to the 
equator seem to have a lower cancer death rate.66 In a 2012 review of ecological studies 
associating solar UVB exposure / vitamin D and cancers, a strong inverse correlation was 
found with solar UVB and 15 types of cancer: Hodgkin’s and non-Hodgkin’s lymphoma, 
breast, cervical, ovarian, endometrial, vulvar, oesophageal, bladder, gastric, colon, rectal, 
lung, pancreatic and renal cancer.18 These studies on association do have particular 
restrictions regarding the establishment of a causality as low vitamin D levels are also 
linked with other confounding aspects that are related to higher cancer risk, including lack 
of physical activity (correlated with less outdoor time and less UV solar exposure) and 
obesity (vitamin D is sequestered in adipose tissue).18 A population-based, double-blind, 
randomised placebo-controlled trial with a duration of four years with 1179 
postmenopausal women (>55 years old), where the principal secondary outcome was 
cancer incidence, showed that with supplementation of calcium (1400–1500mg/day) and 
vitamin D3 (1100 IU/day) the reduction in relative risk (RR) of cancer was approximately 
60% (p<0.01). With the repetition of a cancer-free survival analysis after the first 12 
months it was revealed that the relative risk for the calcium + vitamin D supplementation 
group was reduced by approximately 77% (confidence interval (CI): 0.09–0.60; p<0.005).67 
 
A PubMed database search done by Garland et al. yielded 63 observational studies of 
vitamin D status in relation to cancer risk, including 30 of colon, 26 of prostate, 13 of 
breast, and 7 of ovarian cancer, and several that assessed the association of vitamin D 
and cancer risk. In the majority of studies a protective relationship was found between 
sufficient vitamin D status and lower risk of cancer. The evidence suggests that improving 
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vitamin D status (for example by vitamin D supplementation), could decrease cancer 
prevalence and mortality at low cost, with no or few harmful effects.68 Increasing evidence 
proposes a biological plausibility for anti-carcinogenic effects of vitamin D, which could 
explain these findings.18 Although studies show promising results, there is still not 
conclusive evidence that vitamin D prevents the formation of cancer cells, slows down the 
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1.8.2.2 Cardiovascular risk 
The role of vitamin D in cardiovascular health is a very new and unique field of interest.70 
There are many studies (prospective, epidemiological and meta-analytical) that suggest a 
significant inverse association between vitamin D serum levels and cardiovascular risk.67,68 
The prospective Intermountain Heart Collaborative Study (>40 000 participants) showed 
that levels of 25(OH)D of <15ng/mL when compared with levels of 25(OH)D of >30ng/mL 
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were associated with a significant rise  in hyperlipidemia, hypertension, peripheral vascular 
disease, coronary artery disease, myocardial infarction, stroke, heart failure and type II 
diabetes as well as incident death.18 This data is strongly supported by epidemiological 
and observational data that link vitamin D deficiency to the evidence, degree and 
prevalence of cardiovascular disease conditions and different risk factors. Very little is 
known about vitamin D as a preventative and/or therapeutic agent of cardiovascular 
disease. The limited data on vitamin D as therapy militate against any recommendations to 




1.8.2.3 Autoimmune disease 
In ecological studies it has been shown that the presence of certain autoimmune diseases 
(type I diabetes, multiple sclerosis (MS) and Crohn’s disease) is associated with latitude. 
In these findings rests the potential role of sunlight and thus vitamin D status. At higher 
latitudes there is an increased prevalence for these autoimmune diseases (also 
inflammatory bowel disease and rheumatoid arthritis).18 In one case control study it is 
shown that the risk of multiple sclerosis significantly decreased with increased levels of 
25(OH)D (odds ratio for a 8ng/mL increase in 25(OH)D was 0.59 (95% CI: 0.36–0.97).72 In 
another study addressing the effect of vitamin D on MS the safety of high-dose vitamin D 
(~14 000 IU/day) is highlighted. The noticeable immunomodulatory effects included a 
constant decrease in T-cell proliferation and the result was a trend towards a smaller 
number of relapse episodes.68 There have also been studies where a greater intake of 
vitamin D was inversely associated with the risk of rheumatoid arthritis (RR 0.67; 95% CI: 
0.44–1.00;p=0.05).73 
 
In a nested cohort study an inverse association has been shown between maternal vitamin 
D levels and the risk of type I diabetes in the offspring. In this cohort of 30 000 pregnant 
women, the odds of type I diabetes in the women with the lowest quartile were more than 
twofold higher.74 A birth-cohort study of children (>10 000) showed that regular 
supplementation (2000 IU vitamin D/day) in their first year of life was associated with a 
88% reduction of the risk of type I diabetes later in life compared with children without 
vitamin D supplementation.75 These links point  towards the contributing role that vitamin D 
plays in the pathophysiology of certain autoimmune diseases. Immune cells have both the 
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enzymatic equipment to produce 1,25(OH)2D and a VDR. This might explain why certain 
polymorphisms in the VDR gene appear to influence the risk of numerous autoimmune 
diseases, the time of commencement of the disease, and disease action.18 
 
 
1.8.2.4 Infectious disease 
Vitamin D has a plethora of effects when it comes to regulating the immune system and 
this plays a role in fighting infectious diseases. Vitamin D enhances the natural immunity 
against a variety of infections. Historically, cod liver oil (natural source of high amounts of 
vitamin D (500 IU/5ml)12,38 was given to tuberculosis patients in the 19th and 20th century. 
Patients were also treated with heliotherapy (sun exposure) later in the 19th century. Niels 
Ryberg Finsen was awarded the Nobel Prize for medicine in 1903 for his contribution to 
the treatment of disease, particularly lupus vulgaris (tuberculosis of the skin) with 
concentrated light therapy. After the identification of vitamin D as the active ingredient in 
cod liver oil, it was used in several studies in the treatment of lupus vulgaris. In the 
antibiotic era, the use of heliotherapy and vitamin D treatment in tuberculosis patients was 
relegated to history.18 
 
A reduction in cold and influenza symptoms was revealed in association with vitamin D 
supplementation in a study where the objective actually was to measure bone loss. These 




1.8.2.5 Respiratory diseases 
25(OH)D levels seem to correlate positively with lung function and asthma control and 
inversely with corticosteroid use. Very few intervention studies on vitamin D’s effect on 
asthma exist, but one of them showed as a secondary result that vitamin D3 (1200 IU/day) 
supplementation in children was linked to a significant reduced risk of asthma 
exacerbation. Vitamin D’s immunomodulatory and pulmonary effects most probably play a 
role here.18 




In the narrative review of Pilz et al. the vast majority of prospective observational studies 
show that low 25-hydroxyvitamin D (25(OH)D) concentrations are linked with an increased 
risk of mortality. In the largest meta-analysis including more than 800 000 participants, the 
RR (95% CI) for mortality in the bottom versus the top third of baseline 25(OH)D levels 
was 1.35 (1.22–1.49). When comparing participants with 25(OH)D levels of <10ng/mL 
versus participants with ≥30ng/mL, the RR (95% CI) was 1.5 (1.21–1.87). When assuming 
a linear relationship between 25(OH)D and mortality, every decrease of 10ug/mL was 
associated with a 16% increase in all-cause mortality.76 
 
 
1.9 Risk Factors for Vitamin D Insufficiency and Deficiency 
There are numerous risk factors for hypovitaminosis D (Table 1.3). About 80% of the 
variation amongst individuals’ vitamin D status can be attributed to skin synthesis as a 
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Reduced skin synthesis   
Skin pigmentation  






Latitude >37º north or south 
Season, time of day, weather 
Protective clothing, sunscreen 
Physical inactivity, homebound 
Air pollution 
Decreased intake Unhealthy diet 
Limited supplement intake 
Breastfeeding – low vitamin D content of human milk 
Intestinal malabsorption syndromes 
Parenteral nutrition 
Increased catabolism Glucocorticoids, antiepileptic drugs, HAART (AIDS 
treatment), antirejection medication 
Obesity Increased BMI decreases vitamin D status 
Sequestration of vitamin D in fat stores 
Aging Limited UVB exposure 
Decreased vitamin D intake 
Decreased cutaneous synthesis with age 
Decreased synthesis of 25(OH)D Liver failure 
Reduced synthesis of 1,25(OH)2D Chronic kidney disease 
Heritable disorders Pseudovitamin D deficiency rickets 
Vitamin D resistant rickets 
Acquired disorders Tumour-induced osteomalacia 
Primary hyperparathyroidism 
Hyperthyroidism 
UVB  = Ultraviolet B 
BMI   = Body Mass Index 
HAART  = Highly Active Antiretroviral Therapy 
AIDS   = Acquired Immune Deficiency Syndrome 
25(OH)D  = 25-hydroxyvitamin D 
1,25(OH)
2
D = 1,25-dihydroxyvitamin D 
 
The Fitzpatrick Skin Phototype Classification system is often used for skin 
classification.2,87-91 The skin classification (Table 1.4) is done according to colour of skin 
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Table 1.4: Skin Classification 
The Fitzpatrick Skin Phototype Classification
79
 
Type FZ I: White skin, always burns, never tans 
Type FZ II: White skin, always burns, minimal tan 
Type FZ III: White skin, burns minimally, tans moderately and gradually 
Type FZ IV: Light brown skin, burns minimally, tans well 
Type FZ V:  Brown skin, rarely burns, tans deeply 
Type FZ VI: Dark brown/black skin, never burns, tans deeply 
 
 
MED is the Minimal Erythemal Dose and is defined as the smallest dose of UVB that may 
produce pink erythema (sunburn) 24 hours after exposure. Supposing that unprotected 
skin has been exposed to UV radiation for the first time, to determine the MED, the 
response of the skin will be logged 24 hours after UV exposure. The smallest dose that 
brings on any visible reddening (pink) at that point is defined as one MED. Redness that 
happens immediately after UV exposure, however, and vanishes during the following 3–5 
hours, is mainly the result of heat and is not equivalent to real UV erythema. On this basis 
the reading is not taken until 24 hours later.92 
 
As an example: a young adult with skin type III who was exposed to 1 MED of 54mJ/cm2 
showed a 50-fold rise in blood concentrations of 25(OH)D within 8 hours of exposure, 
whereas an adult of the exact same age group with a skin type V that was exposed to the 
same amount of sun did not exhibit any considerable increase in circulating concentrations 
of 25(OH)D. The adult with skin type V will require 5–10-fold more sun exposure and only 
exhibit a 30-fold increase in blood concentrations of 25(OH)D to ~30ng/mL.2 In general 
darker skin (greater melanin pigmentation) and skin that does not burn easily produce less 
Vitamin D.8 
 
Latitude, time of day and season can significantly influence cutaneous vitamin D 
production. During the months of November to February there are striking decreases       
(~ 80–100% depending on latitude) in the number of UVB photons that reach the earth’s 
surface – that is, above latitude North 37º. Therefore very little or no vitamin D is 
manufactured in the skin during winter months. On the other hand, below 37ºN and closer 
to the equator, more vitamin D can be manufactured throughout the year, but in early 
morning and late afternoon the zenith angle of the sun’s rays can be so slanted that very 
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little vitamin D is produced, even in summer.2 South Africa’s latitude is between 20º and 
35º S.65,93 Johannesburg’s coordinates are 26.2044 ºS, 28.0456ºE and Cape Town’s 
coordinates are 33.9253 ºS, 18.4239ºE.94 
 
Sunscreen lotions work by absorbing UVB and some UVA radiation ahead of its entering 
the skin. A sunscreen with an SPF (Sun Protection Factor) of 8 can decrease the skin’s 
capacity to produce vitamin D by >95%; sunscreens with an SPF of 15 can decrease the 
skin’s capacity by up to 98%.2 
 
Vitamin D3 is a fat-soluble vitamin and therefore stored in body fat. Excess vitamin D3 that 
is produced during sun exposure can be stored in body fat to be used during winter 
months when skin production is reduced. However, for obese individuals, the fat can be an 
irretrievable sink for vitamin D as vitamin D is sequestrated in fat tissue, increasing their 
risk of vitamin insufficiency and deficiency.2 It has been shown that with vitamin D 
supplementation of 50 000 IU, obese subjects show improved blood levels of vitamin D of 
no more than 50%, compared with those of non-obese individuals.2 
 
Low vitamin D intake, advanced age, disease and medication can affect vitamin D 
metabolism.3,8 Gastrointestinal diseases such as Crohn’s disease and Coeliac disease can 
influence vitamin D absorption. Vitamin D status is negatively influenced by pancreatic 
insufficiency with its associated malabsorptions, for example, cystic fibrosis and cholestatic 
liver disease such as primary biliary cirrhosis. Chronic kidney disease is commonly 
associated with low vitamin D status, to some extent owing to reduced action of 25(OH)D-
1∝-hydroxylase. Nephrotic syndrome might cause increased urinary losses of vitamin D 
and vitamin D binding protein.3 
 
It is therefore expected that vitamin D deficiency would be more common in high-risk 
populations6 such as persons who are older, sun deprived, and have sub-optimal nutrition, 
overweight and obese individuals, and those with dark skin such as black and Hispanic 
people.3,8 
 
According to Pramyothin and Holick95 the following candidates are at risk of vitamin D 
deficiency and screening can be warranted in patients with the following conditions:81 
 
 






(4) Chronic kidney disease 
(5) Hepatic failure 
(6) Malabsorption syndromes: 
(A) Cystic fibrosis 
(B) Inflammatory bowel disease 
(C) Crohn’s disease 
(D) Bariatric surgery  
(E) Radiation enteritis 
(7) Hyperparathyroidism 
(8) Medications: 
(A) Antiseizure medications 
(B) Glucocorticoids 
(C) AIDS medications 
(D) Antifungals, e.g., ketoconazole 
(E) Cholestyramine 
(9) African-American and Hispanic children and adults 
(10) Pregnant and lactating women 
(11) Older adults with history of falls 
(12) Older adults with history of non-traumatic fractures 
(13) Obese children and adults (BMI > 30 kg/m2) 
(14) Granuloma-forming disorders: 
(A) Sarcoidosis 
(B) Tuberculosis 
  (C) Histoplasmosis (List adapted from81) 
 
 
1.10 Vitamin D Requirements 
The 2011 report of the Institute of Medicine (IOM) on dietary reference intakes for calcium 
and vitamin D set the adequate intake of vitamin D at 400–800 IU/day (10–20µg/day), 
based on age.18,37,79 The Scientific Advisory Committee (SACN) on Nutrition 2016 report 
on Vitamin D and health recommends a Reference Nutrient Intake (RNI) of 400 IU/day for 
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the UK population aged 4 years and above. According to the SACN, this is the average 
amount of vitamin D needed by 97.5% of the population to maintain serum 25(OH)D levels 
above 10ng/mL (25nmol/L) when UVB sunshine exposure is minimal.85 Dietary Reference 
Intakes (DRI) compiled by the Nutrition Information Centre at Stellenbosch University are 
set at much lower levels of 200–600 IU/day based on age.96 However there is growing 
consensus that vitamin D intakes above these levels are associated with better health 
outcomes.35,84 The Endocrine Society sets a much higher daily requirement of 1500–2000 
IU/day (Table 1.5).18,37 Universal experience with vitamin D demonstrates that vitamin D 
supplementation of 600 IU/day (as the body’s sole input of vitamin D) would not be enough 
to produce even 10 ng/mL, let alone 20 ng/mL or above. To achieve a level of >30ng/mL 
25(OH)D, an intake of at least 800–1000 IU of vitamin D is needed, depending on age.84 
The response increment of vitamin D is 1–0.7ng/mL/100 IU.18,84 The tolerable upper intake 
level (UL) for daily vitamin D according to the DRI is 2000 IU and the UL set by the IOM is 
4000 IU18,37,81 (Table 1.5). The Endocrine Society sets tolerable upper intake levels at 
10 000 IU.37 
 
Veugelers and Ekwaru recently published an open letter in Nutrients (2014) titled: “A 
Statistical Error in the Estimation of the Recommended Dietary Allowance for Vitamin D”.94 
In their calculations they found that the regression line revealed that 600 IU of vitamin 
D/day achieve that 97.5% of individuals will have serum 25(OH)D values above 10.7ng/mL 
(26.8 nmol/L) rather than >20ng/mL (50nmol/L) as currently assumed. It is then estimated 
that 8895 IU of vitamin D per day may be needed to accomplish 97.5% of individuals to 
achieve serum 25(OH)D values >20ng/mL(50 nmol/L). As this dose is far greater than the 
range of studied doses, caution is warranted when interpreting this new estimate. 
Nevertheless, the very high estimate only illustrates that the dose is well in excess of the 
current RDA of 600 IU/day and even the tolerable upper intake of 4000 IU/day.18,37 It is 
stated that with the current recommendation of 600 IU/day of the IOM, bone health 
objectives and disease and injury prevention targets will not be met. This is demonstrated 
in two studies conducted in Canada with total vitamin D intake of 632 IU/day (dietary 
intake 232 IU/day and supplementation of 400 IU/day), where 10% of participants had 
values of <20ng/mL (<50nmol/L). The second study reported serum 25(OH)D levels of 
<20ng/mL (<50nmol/L) for 15% of participants who reported supplementation with vitamin 
D. If the IOM’s RDA had been adequate, these percentages should not have been greater 
than 2.5%. These studies then show that the current public health targets are not being 
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met.94 The authors recommend “that the RDA for vitamin D be reconsidered to allow for 
appropriate public health and clinical decision-making”.94 
 
Table 1.5: Vitamin D Recommendations for Adults 18 years to >70 years 

































Years IU/day  IU/day IU/day  IU/day IU/day IU/day IU/day IU/day IU/day 





31–50 200 2000 2400 3800 400 600 4000 1500–2000 
51–70 400 2000 2400 3800 400 600 4000 1500–2000 
>70 600 2000 - - 400 800 4000 1500–2000 
Female 18–30 200 2000 2400 3800 400 600 4000 1500–2000 
31–50 200 2000 2400 3800 400 600 4000 1500–2000 
51–70 400 2000 2400 3800 400 600 4000 1500–2000 
>70 600 2000 - - 400 800 4000 1500–2000 
1µg =40 IU                                                                                                                                                                        
DRI =Dietary Reference Intake                                                                                      
 AI = Adequate Intake                                                                                                     
 UL    = Tolerable Upper Intake Level      
NOAEL = No Observed Adverse Effect Level   
LOAEL = Lowest Observed Adverse Effect Level                                                                        
 IOM   = Institute of Medicine    
EAR = Estimated Average Requirements       
RDA = Recommended Dietary Allowance       
 NRV     = Nutrient Reference Values   
 
 
1.11 Vitamin D and Sun Exposure 
The exposure of the skin to sunlight will provide most humans with their vitamin D needs. 
Ageing diminishes the skin’s ability to produce vitamin D3, because the vitamin D 
forerunner, 7-dehydrocholesterol, decreases with age. The ability of the human skin to 
manufacture vitamin D3 is so sufficient that even a 70% drop in the skin’s 7-
dehydrocholesterol levels by age 70 does not stop the elderly from producing adequate 
quantities of vitamin D3 in their skin from casual sun exposure outdoors.
2,14 It should be 
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noted that a sunscreen with a sun protection factor (SPF) of 30 can absorb about 99% of 
the UVB radiation responsible for making vitamin D3.
14 
 
A single session of sunlight exposure to the whole body (in a bathing suit), just sufficient to 
produce erythema (minimal redness to the skin) (1 minimal erythemal dose), yields about 
10 000–25 000 IU vitamin D3.
7,35,86 Increased skin pigmentation can reduce the skin’s 
production of vitamin D37,98 as shown in the study done between South Asian and white 
groups by Farrar et al., where the recommended exposure to sunlight did not produce 
sufficient vitamin D status in the Asian group.98 Melanin absorbs both visible and UV 
radiation as revealed by in-vitro studies where UVB transmission in black epidermis is less 
than a quarter than that in white epidermis.99 
 
There can be large fluctuations in serum 25(OH)D levels from late summer to late winter. 
A drop of 0.11ng/mL per day was recorded by Barger-Lux and Heaney, a fall from 48.8 to 
29.6ng/mL over 175 days.86  In Cape Town, South Africa, the study of Haarburger et al. 
showed no significant difference between the medians (18.8ng/mL versus 19.5ng/mL) for 
summer versus winter values.30 
 
The highest 25(OH)D attainable by sun exposure is in the region of 60– 80ng/mL.15,35 
Similar results were found by Barger-Lux and Heaney.86 Among Nebraskan outdoor 
labourers the three highest measurements reported were between 81 and 84ng/mL. The 
assay used in this study measured other vitamin D metabolites as well as 25(OH)D and 
consequently resulted in higher values.15 
 
Current clinical recommendations indicate the following: Exposure of arms and legs, not 
face (without sunblock) to sunlight, 15–30min two or three times a week between the 
hours of 11:00 and 15:00 during the spring, summer and autumn for individuals with skin 
type II or III, (depending on time of day, season, latitude and skin pigmentation).2,16,31,35, 
For example, at latitudes above 37ºN, from about mid-October to mid-March, the solar 
angle is such that no vitamin D is converted in the skin.35 For these reasons high amounts 
of sun exposure will not always ensure acceptable levels of vitamin D adequacy.15,86 This 
implies that the common clinical recommendation for sun exposure may not ensure 
vitamin D sufficiency in all population groups.15 
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The Endocrine Society’s Clinical Practice Guidelines also recommend sensible sun 
exposure, which in many cases is the most important source of vitamin D for most 
individuals, provide a list of vitamin D-rich food, and encourage taking a daily supplement 
of vitamin D to ensure adequate 25(OH)D levels.18,37 
 
The Scientific Advisory Committee on Nutrition states in its 2016 report that “it is not 
possible to make any recommendations regarding the amount of sunlight exposure that 
would be required during the summer to maintain serum 25(OH)D concentration 
≥10ug/mL(25nmol/L) in 97.5% of the UK population during the following winter because of 
the number and complexity of factors that affect endogenous vitamin D production”.85 
 
 
1.12 Vitamin D Supplementation 
Oral vitamin D supplements are obtainable as vitamin D3 or D2. Vitamin D3 
supplementation is usually favoured over D2 because D2 may be less bioactive and may 
have lesser affinity for the VDR, but data are inconsistent.6 In the systematic review and 
meta-analysis of Tripkovic et al., it was indicated that supplementation with vitamin D3 had 
a significant and positive effect in the raising of 25(OH)D serum levels when compared 
with the effect of vitamin D2 (mean difference: 15.3nmol/L; 95% CI: 6.12,24,34; 
p=0.001).100 The only high-dose vitamin D available in South Africa is prescription 
formulation of vitamin D2, Lennon-Strong calciferol tablets (50 000 IU), and calciferol oily 
solution – Lennon (5 000 IU/ml), both Schedule 3.6 The guidelines with regard to the 
quality, safety, dosage  and efficacy requirements for the registration of health 
supplements are published by the Medicines Control Council (MCC) of South Africa. The 
guidelines have recently been updated. The permissible levels and claims for vitamins are 
contained in the MCC Complementary Medicines – Health Supplements Quality, Safety 
and Efficacy document Version 2 published in June 2016. The first version was published 
in November 2014 and opened for comments until 26 February 2015.101 The document is 
available at http://www.mccza.com/Publications/Index/1.The maximum vitamin D dose that 
is allowed in an over-the-counter supplementation is 1000 IU.101 Metagenics® D3 5000 IU 
and 2000 IU are dispensed on prescription, but are not scheduled. Table 1.6 gives a list of 
vitamin D supplements available in South Africa. Many multivitamins also contain vitamin 
D, but not in therapeutic doses.39 
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The evidence for proposed vitamin D supplementation to maintain sufficient 25(OH)D 
serum levels (>30ng/mL) in the absence of adequate sun exposure remains inconclusive. 
Previous recommendations were 1000 IU/day of vitamin D3,
8,16 but a more recent six-
month supplementation trial suggests that up to 4000 IU/day may be needed to produce 
serum levels >30ng/mL.8 
 
The Endocrine Society suggests that all adults aged 19–70 years and 70 years or older 
require at least 600 and 800 IU/day respectively, of vitamin D. Whether 600 and 800 
IU/day vitamin D will be enough to provide all the potential non-skeletal health benefits is 
not known at this time. However, to elevate the blood level of 25(OH)D above 30ng/mL 
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Table 1.6: Supplemental Sources of Vitamin D in South Africa 
Supplement Source Amount (per tablet) 
µg IU 
Cholecalciferol (D3) 
Multivitamin (various preparations available) 
   Certain calcium supplements (package insert) 
   D-Vit® Tabs (Georen) (package insert) 
   D-Drops® (Georen) (/0.5ml) (package insert) 
Vitamin D3 (SOLAL
®) (package insert) (2014) 
Vitamin D3 (SOLAL
®) (package insert) (since 2016) 
   Vitamin D (ReVite
TM
) 
   Vitamin D3 (Biogen
®) (package insert) 
   Vitamin D complex (Foodstate®) (Package insert) 
   Vitamin D3 drops (Colief
®) (/drop) (package insert) 
   D3 5000 (Metagenics/Amipro) (package insert)
a 
 D3 2000 Complex (Metagenics/Amipro) (packageinsert)
a 
   D3 1000 (Metagenics/Amipro) (package insert) 
































Lennon-Strong calciferol tablets (Schedule 3) (package insert)   








Cernivit® multivitamin preparation for intravenous or  intramuscular 
injection (5ml vial) (D3) (package insert) 

















 (alphacalcidol) Adcock Ingram (Schedule 
4) (package insert) 
Rocaltrol
®
 0.25µg and 0.5µg capsules (calcitriol) Roche (Schedule 4) 
   (vitamin D metabolite) 
Vitamin D3 transdermal patch
c 






















Metagenics vitamin D3 only available on prescription but not scheduled  
b




Current clinical trial underway to test if a transdermal patch will safely and successfully deliver vitamin D3 in 
humans. ClinicalTrials.gov Identifier: NCT02174718.
41
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The Endocrine Society Clinical Practice Guidelines suggest one 50 000 IU capsule of 
vitamin D2 per week for 8 weeks,
8,18 followed by 50 000 IU every 2–4 weeks thereafter, is a 
cost-effective approach to correct vitamin D deficiency and maintain sufficient levels.8 
Otherwise ~6000 IU/day of vitamin D3 or D2 should be taken to achieve blood levels above 
30ng/mL. This must be followed by maintenance therapy of 1500–2000 IU/day.37 In obese 
patients, malabsorption syndromes and patients on medication that can affect vitamin D 
metabolism, 2–3 times higher dosages (6000–10 000 IU/day) of vitamin D are suggested 
to treat vitamin D deficiency. This must be followed with maintenance therapy of at least 
3000–6000 IU/day(Table 1.7).37,81 The approach of supplementing with 50 000 IU of 
vitamin D fortnightly to prevent recurrence and treat vitamin D insufficiency and deficiency 
was followed for six years without toxicity.18 
 
Table 1.7: Recommended treatment strategies according to the Endocrine Society Clinical Practice 
Guidelines for adults with vitamin D deficiency 
Age / Co-morbidity Recommendation: Using vitamin D2 or D3
37,81 
Adults over 18 years 50 000 IU
a
 once a week for 8 weeks, followed by 50 000 IU every 2–4 weeks 
thereafter or 
6000 IU daily for 8 weeks to achieve a blood level of vitamin D >30ng/ml followed 
by maintenance therapy of 1500–2000 IU/day. 
Obesity, malabsorption, 
or medications affecting 
vitamin D metabolism 
Two to three times higher dose; at least 6000–10 000 IU per day to achieve a 




Treatment as needed, with serial monitoring of serum calcium.  
Most patients will not increase their serum calcium, and serum PTH
b
 may even 
decrease. 
a




In the narrative review of Pilz et al., observational data and meta-analysis of RCTs found 
that vitamin D3 supplementation reduces overall mortality. Supplementation of any type of 
vitamin D versus placebo reduced mortality, but vitamin D3 supplementation was 
associated with significant mortality reduction and a risk ratio (95% CI) of 0.94 (0.91– 
0.98). Based on this finding, it was calculated that 150 individuals needed to be treated 
with vitamin D3 over five years to prevent one death. These findings provide a strong 
rationale in favour of the safety and benefits of vitamin D supplementation.76 
Stellenbosch University  https://scholar.sun.ac.za
38 
 
1.13 Vitamin D Intoxication 
Vitamin D intoxication cannot be caused by excessive exposure to sunlight because any 
excess previtamin D3 or vitamin D3 is destroyed by sunlight.
8,16,101 
 
Toxicity from vitamin D supplementation is uncommon and consists mainly of acute 
hypercalcaemia and hyperphosphataemia, with doses greater than 10 000–50 000 IU per 
day; related serum levels of 25(OH)D are >150–200ng/mL.2,3,8,16,35 Two cases of 
intoxication were recently reported by Araki et al., where the cause of the intoxication was 
due to labelling and manufacturing errors of two supplements made in the United States. 
Even with toxic dose estimated at 100 000 IU/day for a month, these two cases were 
taking nine and 18 times more respectively.103 Clinical symptoms include lethargy and 
confusion, muscle weakness, nausea, vomiting and dehydration.35,104 Vitamin D 
intoxication is associated with the hyper-absorption of phosphorus and calcium. 
Manifestations of vitamin D toxicity include ectopic soft tissue calcification, including 
vascular calcification, hypercalcaemia, hypercalciuria, nephrocalcinosis, and renal 
failure.95 
 
No cases of vitamin D toxicity have been reported with vitamin D supplementation doses 
less than 10 000 IU/day (approximately 120–200 IU/kg body weight/day).35 The risk of 




1.14 Sun Exposure and Cancer Risk 
According to the World Health Organization (WHO) Global Burden of Disease from Solar 
Ultraviolet Radiation (UVR) Report, globally excessive UVR exposure contributes to 0.1% 
of the global burden of disease [1.5 million Disability-Adjusted Life Years (DALYs)] where 
the greatest burden results from UVR-induced cortical cataracts, cutaneous malignant 
melanoma, and sunburn. It should be noted that the counterfactual of zero UVR exposure 
will not result in a lesser disease burden, but will rather result in a higher disease burden 
owing to diseases from vitamin D deficiency.105 
 
There are three major types of skin cancer: Basal Cell Carcinoma (BCC), consisting of 
raised, translucent pearly nodules that occur mostly on the face and other exposed areas; 
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Squamous Cell Carcinoma (SCC), usually with raised, pink opaque patches or nodules 
that can frequently form sores or ulcers in the centre and appear most often on exposed 
areas of the body; and Cutaneous Melanoma (CM), comprising small brown, black or 
multi-coloured patches that have an irregular outline. These can occur from pre-existing 
skin spots or moles or can appear in normal skin.106 
 
Australia has the highest incidence of skin cancer in the world, followed by South Africa’s 
white population, with about 20 000 reported cases every year and about 700 deaths. 
Reports by the WHO estimate that there are between 2–3 million non-melanomas and 
about 132 000 cutaneous melanomas globally every year.106 
 
In South Africa the highest annual incidence of all three types of skin cancer occurs in the 
white population, followed by coloured, Asian and black population groups. BCC and SCC 
are twice as common in males as in females, and melanoma is the least frequent skin 
tumour, with BCC the most frequent diagnosed skin tumour.107 
 
The relationship between sun exposure and skin cancer (BCC and SCC) has been 
established since 1927, and since 1955 for melanoma.108 The relationship between the 
different types of skin cancer and sun exposure is quite complex as there are many factors 
to consider. There is the relationship with ambient solar irradiance, which includes 
population location, personal residence history, and migration. Then there is also the 
relationship with cutaneous sun sensitivity, which includes ethnic origin, colour of 
unexposed skin, and the ability to tan. There is also the relationship with personal sun 
exposure and body areas exposed to the sun. This includes total lifetime exposure, recent 
total exposure, occupational exposure, non-occupational exposure, and sunburn.108 
 
The Cancer Association of South Africa (CANSA) contends at least 80% of sun-induced 
damage to the skin occurs before the age of 18 and manifests later in life. Therefore skin 
protection is very important in children. People with light skin, red hair and skin spots or 
moles, as well as people with a family history of skin cancer, are considered to be at high 
risk.106 Tanning booths and sun beds can double the melanoma risk of an individual and 
can thus not be considered a safe alternative to sun exposure.106 CANSA advocates the 
avoidance of direct sunlight between 10:00 and 15:00, the use of sunscreen and protective 
clothing, and the avoidance of sunlamps and tanning parlours.106 
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The relationship between skin cancer and sun exposure remains very complex. Juzeniene 
et al. found that occupational sun exposure does not increase the risk of CM, but that CM 
rates are more related to intermittent and intense sun exposure and sunburn than the total 
dose of sun exposure. Sun exposure actually leads to melanin generation and skin 
thickening, both of which are presumably protective factors. Sun exposure also generates 
vitamin D that is probably anti-melanogenic. It is evident in incidence-exposure curves that 
zero exposure does not result in a zero incidence. The fact that there is similarity in density 
between melanomas on sun-exposed areas and sun-shielded areas only emphasises the 
need for more research in the area to identify non-UV factors that are associated with skin 
cancer. Current analyses do not identify “safe” UV doses where the risk of skin cancer is 
not present. The avoidance of sun exposure has the possibility to decrease the incidence 




A renowned vitamin D researcher, Dr MF Holick, states that “vitamin D deficiency is now 
recognized as one of the world’s most common medical conditions”.14 In many countries 
throughout the world mean serum vitamin D levels are around 20ng/mL; this implies that 
vitamin D insufficiency exists in about 50% of these populations.24 The 25-hydroxyvitamin 
D (25(OH)D) assay is the most-ordered hormone assay in the United States.14,35 
 
Current research has revealed that optimal vitamin D status may be essential for a range 
of skeletal and non-skeletal outcomes.2,6 Vitamin D can no longer be just the nutrient for 
the prevention of rickets among children, but vitamin D should be regarded as necessary 
for overall health and wellbeing.2 
 
The present body of evidence is significant enough to validate that health care 
professionals should be encouraged to recognise the vitamin D deficiency pandemic and 
to take appropriate steps to prevent and treat this widespread condition14 by 
recommending sensible sun exposure, food containing vitamin D in the diet, and vitamin D 
supplementation.18 Increasing and maintaining a sufficient 25(OH)D (>30ng/mL) worldwide 
in the general adult population without rare conditions associated with an increased risk of 
vitamin D toxicity will help to improve overall health and wellbeing and should be a main 
concern.2,18 A ‘healthy lifestyle’ that includes outdoor activities with carefully balanced 
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sunlight exposure, together with efforts to combat the global burden of obesity, would 





The current body of research on vitamin D and its skeletal and non-skeletal functions 
sparked a new interest in this long-forgotten vitamin. Data on vitamin D status in South 
African adults is limited114 and on examining data from other sunny countries15,50 it can be 
concluded that we cannot just assume that the population will be vitamin D sufficient. 
 
In 2011 Parry et al. conducted vitamin D status screening in pre-operative orthopaedic 
paediatric patients and ascertained that 90% of patients had insufficient vitamin D levels, 
while 51% were deficient.44 
 
To the author’s knowledge, in South Africa vitamin D status in the pre-operative adult 
orthopaedic private patient has not been investigated. Also, obese patients are operated 
on an average of ten years earlier than their normal BMI counterparts. The vitamin D 
status of orthopaedic patients can influence their orthopaedic outcome in the future as 
vitamin D has been linked to falls and fractures. Identifying patients or populations as at 
risk groups can help prevent future major surgical interventions. South Africa has 
abundant sunshine, but there are many other factors that can influence vitamin D status, 
such as sun exposure (clothing and use of sunscreen), skin pigmentation, and dietary 
vitamin D intake, to name but a few. This study aims to shed some light on these factors 
by assessing vitamin D status pre- and also post-operatively, thus examining the effect of 
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In choosing orthopaedic surgical patients as the population for this study, a number of 
questions may be addressed, namely, the: 
 determine if the orthopaedic surgical population is an ‘at risk’ population 
 vitamin D status of this population;   
 vitamin D oral intake of this population; 
 sun-exposure habits of this population; and 
 impact of minor and major orthopaedic surgical interventions and the recovery 






































































2.1 Aim and Objectives 
2.1.1 Aim 
To determine the vitamin D status of orthopaedic surgical patients and the impact of the 




2.1.2.1 To determine the vitamin D status of orthopaedic patients on admission to a private 
hospital in Johannesburg, South Africa. 
2.1.2.2 To determine if there is a relationship between 25(OH)D and the following: 
 Demographic parameters (gender, age, smoking and skin classification) 
 Anthropometric status (BMI and waist circumference) 
 Sun exposure (calculated sun index) 
 Vitamin D intake (supplementation and dietary intake) 
2.1.2.3 To determine vitamin D status after the surgical intervention. 
2.1.2.4 To determine if there is a change in the following: 
 Sun exposure (calculated sun index) after surgical intervention (comparison of sun 
exposure [calculated sun index] before and after surgery) 
 Vitamin D intake after surgical intervention (comparison of vitamin D intake before 




2.2.1 The orthopaedic surgical population have insufficient vitamin D levels and can be 
classified as an ‘at risk’ group. 
2.2.2 There is no statistically significant relationship between 25(OH)D pre-operatively as 
well as post-operatively and: 
 Demographic parameters (gender, age, smoking, and skin classification) 
 Anthropometric status (BMI and waist circumference) 
 Sun exposure (calculated sun index) 
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 Vitamin D intake (supplementation and dietary intake). 
2.2.3 There is no statistically significant change in sun exposure (calculated sun index) 
after orthopaedic surgical intervention compared with the pre-surgery status. 
2.2.4 There is no statistically significant change in vitamin D intake after orthopaedic 
surgical intervention compared with the pre-surgery intake. 
2.2.5 There is no statistically significant change in 25(OH)D after orthopaedic surgical 
intervention compared with the pre-surgery status. 
 
 
2.3 Study Plan 
2.3.1 Study type 
Descriptive observational cohort study with an analytical component. 
 
 
2.3.2 Study population 








2.3.4 Sample selection and size 
The sampling frame consisted of adult orthopaedic surgical patients at Netcare Mulbarton 
Hospital, Johannesburg, Gauteng. The total required sample size was calculated in 
consultation with a statistician (Professor DG Nel) of Stellenbosch University. To 
determine statistically significant change in vitamin D status, sun exposure and vitamin D 
intake after orthopaedic surgical intervention compared with the pre-surgery status, a 
minimum of 67 patients was required according to the one-way ANOVA power analysis 
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with a small-to-medium effect size (RMSSE=0.40) with 90% power. The same group was 
used in pre- and post-operative testing. 
 
 
2.3.5 Inclusion criteria 
 All adult orthopaedic patients admitted to the hospital for elective orthopaedic surgical 
procedures  
 Age: 18 – 75 years  
 Consent given  
 
 
2.3.6 Exclusion criteria 
 Major orthopaedic trauma patients 
 Immobile and/or bedridden patients 
 Institutionalised patients 
 Patients with the following medical conditions that could influence vitamin D 
status:16 
o Renal impairment                                                                                                                                                                        
Nephrotic syndrome    
o Chronic kidney disease stages 2–4 
o Liver failure 
o Liver dysfunction of 90% or more 
o Gastrointestinal surgery that influences absorption 
 Patients using the following medication that could influence vitamin D status:16 
o Anticonvulsants  
o Glucocorticoids  
o Highly Active Antiretroviral Therapy (HAART) (HIV/AIDS treatment) 
o Anti-rejection medication  
o Steroids: long-term or high doses 
 Rare conditions affecting vitamin D status:16 
o Inheritable disorders: e.g. resistant rickets and autosomal dominant   
hypophosphatemic rickets 
o Acquired disorders: e.g. tumour-induced osteomalacia  
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2.4 Methods of Data Collection 
2.4.1 General procedure 
Patients were identified from orthopaedic surgeons’ theatre rosters with the help of the 
surgeons’ assistants (Figure 2.1). Patients were invited to participate in the study in the 
ward after hospital admission. Once the patient had agreed to participate, arrangements 
were made to meet with them in the surgical ward before the scheduled surgery. 
 
At the first meeting the study was explained in detail and written consent was obtained 
(Addendum A). All questionnaires were in English; however the investigator was able to 
translate any questions into Afrikaans during the interview.  
 
Anthropometric and biochemical measurements were taken pre-operatively and all 
relevant questionnaires (anthropometric and biochemical, demographic, skin classification, 
sun exposure and short food questionnaire for vitamin D) were completed (Addenda B– F). 
Arrangements were made to have the blood sample taken pre-operatively. Lancet 
Laboratories (located on the hospital premises) were called and a Lancet sister took the 
blood sample in the surgical ward. 
 
The second meeting was arranged telephonically where the patient was asked to visit 
Lancet Laboratories at Mulbarton Hospital for the post-operative blood sample. The follow-
up visit was done 55–120 days later. The previously planned follow-up period of about a 
month did not coincide with follow-up visits with the orthopaedic surgeon, as most (88%) of 
the surgeries performed were minor surgeries that required no or few follow-up visits. The 
planned period of approximately a month was also extended as it was revealed in the 
literature that the whole-body, half-life of radio-labelled vitamin D is approximately two 
months.45 The post-operative study population consisted of 23 participants (34% of pre-
operative group). Follow-up response was quite low, despite numerous reminders, phone 
calls and messages. Patients were lost to follow-up because of their unavailability, not 
arriving for scheduled appointments, and transport difficulties. It is suspected that the 
research follow-up did not coincide with the surgical follow-up because of the large number 
of minor orthopaedic surgeries (88%). Surgical follow-up in these cases was often 
between one and two weeks. The proposed follow-up for the research was much later (7–
17 weeks). This longer timeframe was planned to take into account the long half-life of 
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vitamin D (up to six weeks) and the timeframe was extended in an attempt to increase 
follow-up numbers.  
 
At the second visit the investigator met the patients at Lancet Laboratories where the 
relevant questionnaires were completed (sun exposure and short food questionnaire for 
vitamin D) (Addenda E and F). If the investigator was unable to meet the patient at Lancet, 
the questionnaires were completed telephonically within 48 hours of the blood sample 
being taken.  
 
All data collection components were undertaken by the researcher (dietician) with the help 
of a nursing sister (drawing of blood samples only). 
 
 
2.4.2 Anthropometric measurements 
Anthropometric measurements (Addendum B) were taken during the first meeting (pre-
operative) in the surgical ward of Mulbarton Hospital at the patient’s bedside with curtains 
drawn to ensure privacy. Measurements were taken by the researcher (dietician). See 
Table 2.1 for details of the measurements. 
 




Figure 2.1: Conceptual Framework of Study Plan 
 
Patients Identified from theatre 
lists 
(8 April 2014 - 
 2 September 2014) 









Skin Type Classification 
Calculated Sun Index 




 Blood sample obtained by 
Lancet Laboratories for      
25 hydroxyvitamin D 
 
 
Patients contacted for follow-up 
(50 - 120 days post-operatively) 
Post-operative Questionaires: 
At Lancet or telephonically 
Calculated Sun Index 
Short Food Questionaire for 
vitamin D 
Patients met at Lancet:  
(post-operatively) 
 Blood sample obtained by 
Lancet Laboratories for             
25 hydroxyvitamin D  
 
Data recorded, captured and 
analysed 
 Results written up in thesis 
format 
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 Scale was placed on a flat hard surface. 
 Measurements done after bladder had been 
emptied and before a meal. 
 Measurements without shoes and with minimal 
clothing (theatre gown). 
 Subject stood in the centre of the platform and 
looked straight ahead, standing unassisted, 
relaxed but still. 
 Presence of notable oedema was recorded. 
 Body weight was recorded to the nearest 0.1kg. 
 Three measurements were taken (average used) 
 
 Checked and adjusted 











 Nothing coved the head. 
 Patient looked straight ahead with Frankfurt plane 
horizontal. 
 Shoulders were relaxed. 
 No shoes or socks. 
 Feet were together and flat on the floor. 
 Knees were straight. 
 Heels, buttocks and shoulder blades were in 
contact with the vertical surface of the stadiometer.  
 Arms were hanging loosely at the sides with palms 
facing the thighs. 
 Subjects were asked to take a deep breath and 
stand tall to aid the straightening of the spine. 
 Shoulders were relaxed. 
 The movable headboard was gently lowered until it 
touched the crown of the head. 
 The height measurement was taken at full 
inspiration. 
 Height was recorded to the nearest millimetre. 








 Measurement was taken over minimal clothing. 
 Measurement was taken at the natural waist i.e. 
midway between the tenth rib (the lowest rib 
margin) and the iliac crest. 
 In obese subjects measurements were taken at the 
umbilical level, as it was difficult to gauge the 
waistline. 
 Subjects stood erect with abdomen relaxed, arms 
at the sides, feet together and weight equally 
divided over both legs. 
 Subjects were asked to breathe normally and to 
breathe out gently at the time of the measurement. 
 Measurements were taken without tape 
compressing the skin. 
 Readings were taken to the nearest millimetre. 
 Three measurements were taken (average used). 
 








Four questionnaires were used in this study to obtain information: 1. Demographic 
Questionnaire (Addendum C); 2. Skin Type Classification (Addendum D); 3. Sun Exposure 
(Addendum D); 4. Short Food Questionnaire for Vitamin D (Addendum F). 
 
All questionnaires were completed by the investigator (dietician) in a face-to-face interview 
in a private setting to ensure confidentiality on the day of admission to the surgical ward. 
All questionnaires were available in English; however the investigator was able to translate 
any questions into Afrikaans during the interview. The majority of patients at Netcare 
Mulbarton Hospital are English or Afrikaans literate, thus English and Afrikaans were 
adequate for communication. The questionnaires were compiled by the investigator and 
based on the latest literature. For the follow-up visit, patients visited Lancet Laboratories 
for the biochemical assessment. This opportunity was used to complete the sun exposure 
(Addendum D) and short food questionnaire for vitamin D (Addendum F) again. If the 
investigator was unable to conduct interviews at Lancet, the patient was telephoned within 
48 hours to complete the questionnaires telephonically.  
 
 
2.4.3.1 Demographic questionnaire 
The demographic questionnaire (Addendum C) consisted of 19 questions. These included 
questions related to personal information (gender, age, date of birth, language and ethnic 
group) (six questions), medical history (chronic disease, medication and supplementation) 
(eight questions), smoking habits (four questions), and planned surgery (one 
question).This questionnaire was only completed once (pre-operatively). 
 
 
2.4.3.2 Skin-type classification 
Patient skin-type classification (Addendum C) was determined in the first interview on 
admission. The Fitzpatrick Skin Phototype Classification system is widely used for skin 
classification.54,56 Skin classification (see Table 1.3) is done according to colour of skin and 
its ability to burn or tan. Skin classification is done as one of six skin phototype options 
(Figure 2.2)112. Questions included identifying colour of skin as white, light brown, brown or 
dark brown/black; and burning as always burns, burns minimally, rarely burns or never 
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burns. Final questions were on tanning, including never tans, minimal tan, moderate and 
gradual tan, tanning well, or deep tan. This questionnaire was only completed once (pre-

























2.4.3.3 Sun exposure 
Patient-calculated sun index (sun exposure) (Addendum E) was determined in the first 
interview pre-operatively and again at the follow-up in a direct interview or telephonically 
(post-operatively) to determine if habits had changed after the surgical intervention. 
 
Sun exposure was calculated as follows: Calculated sun index = self-reported hours of sun 
exposure per week (Table 2.2) multiplied by the fraction of Body Surface Area (BSA) 
exposed to sunlight.15,86,113 (Table 2.3). 
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Clinical recommendation: exposure, not face (without sunblock) to sunlight 15–30min two 
or three times a week (30min X 3 = 1.5 hours); exposure of arms (0.14 BSA) and legs 
(0.24 BSA) (Total BSA = 0.14 + 0.24 = 0.38).2,16,31,35 
 
A calculated sun index of 0.615 is obtained with sun exposure equivalent to the clinical 
recommendation. (1.5 X 0.38 = 0.615). A calculated sun index below or above the clinical 
recommendation could then be compared to vitamin D status. 
 
Table 2.2: Self Reported Sun Exposure per Week
114 




Weekdays   
< 15 minutes / day   
15–30 minutes / day   
30–60 minutes / day   
1–2 hours / day   
>2 hours / day   
Weekends   
< 15 minutes / day   
15–30 minutes / day   
30–60 minutes / day   
1–2 hours / day   
>2 hours / day   
Calculated hours per week   
    
 
Sun exposure during the previous month on weekdays and weekends between sunset and 
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No hat Hat 
Both arms 0.18 0.18 0.04 0.14     
Both legs 0.36    0.24 0.00   
Anterior 
trunk 
0.18 0.09 0.00 0.00 0.00 0.00   
Posterior 
trunk 
0.18 0.09 0.00 0.00 0.00 0.00   
Head 0.09      0.07 0.03 
Perineum 0.01    0.00 0.00   
Column 
Totals 
1.00 0.36 0.04 0.14 0.24 0.00 0.07 0.03 
ᵃ The “rule of nines” estimates sectors of adults’ BSA as percentages that are multiples of 9.15,86 The rule 
was adapted to estimate the fraction of BSA exposed to sunlight by each subject’s usual outdoor attire, 





2.4.3.4 Short food questionnaire for Vitamin D 
The patients’ dietary vitamin D intake (Addendum F) was determined in the first interview 
on admission and again on follow-up to determine if habits had changed after the surgical 
intervention. 
 
The short food questionnaire for vitamin D was adapted from Blalock et al.117 Permission 
to adapt and use the questionnaire was obtained from the author (24 January 2012). The 
basic format of the form was retained (how often and how much of a food item was eaten). 
The form was adapted by the addition of South African foods with the highest vitamin D 
content (13 changes were made). These foods were identified from the Condensed Food 
Composition Tables for South Africa38 and FoodFinder 3 Software.21 Vitamin D fortification 
is not very common in South Africa. Only margarine, health bars and certain cereals are 
fortified.  
 
The purpose of this questionnaire was to determine the vitamin D intake from food over 
the past three months. First, for each food listed (19 foods), mark the column to show how 
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often, on average, the patient had eaten the food during the past three months. Secondly, 
mark whether the usual serving size was small, medium, or large. Specify margarine, 
health bar and cereal brands (Addendum F). 
 
Average daily vitamin D intake was calculated from data collected and compared with DRI 




Blood collection was done by the trained staff of Lancet Laboratories according to their 
specified procedures (Addendum G).118 Vitamin D status was determined with serum level 
of 25-hydroxyvitamin D by Lancet Laboratories using the ABBOTT ARCHITECT 25OH 
TOTAL VIT D Assay (an automated chemi-luminescent immunoassay).119 
 
A follow-up vitamin D test was done after 55–120 days post-operatively at Lancet 
Laboratories, Mulbarton Hospital. Patients were contacted telephonically on numerous 
occasions to remind them of follow-up blood tests for vitamin D testing. After 120 days, 
patients that did not return for blood tests were recorded as lost to follow-up. 
 
Lancet Laboratories use the following cut-off points on their pathology reports for vitamin 
D25: severe deficiency, <10ng/mL; moderate deficiency, 10–29ng/mL; sufficiency, 30–
100ng/mL; and toxic, >100ng/mL. 
 
 
2.5 Analysis of Data 
2.5.1 Statistical analysis of data 
Data was recorded on a pre-coded data-collection sheet, then captured in Microsoft Office 
Excel 2007 and processed to obtain results. 
 
Data was analysed with the assistance of a statistician, Ms Tonya Esterhuizen from the 
Biostatistics Unit, Centre for Evidence-Based Health Care, Stellenbosch University. SPSS 
Version 22 (IBM® 2013) was used to analyse the data. 
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Summary statistics were used to describe the variables. Distribution of variables was 
presented with histograms and frequency tables. Medians and means were used as 
measure of central location for ordinal and continuous responses. Standard deviations and 
quartiles were used as indicators of spread. When data was skewed, median and 
interquartile ranges were used rather than mean and standard deviation. 
 
A p-value of p<0.05 indicated statistical significance in hypothesis testing. Scatter plots 
were used to illustrate correlation before calculating the correlation coefficient. If the 
variables were normally distributed between two variables, the Pearson correlation 
coefficient was calculated (age and gender). If either or both of the variables had a skewed 
distribution or had outlying values, a non-parametric correlation coefficient was calculated 
based on the ranks of the observation (Spearman’s rank correlation coefficient). Other 
tests used were t-test, one-way ANOVA, Wilcoxon signed-rank test, chi-square test and 
Fisher’s exact test. 
 
Correlations between vitamin D status and calculated sun index (sun exposure) and 
vitamin D intake were made. Correlations were made between pre- and post-operative 
vitamin D status, vitamin D dietary intake, and sun exposure habits. 
 
 
2.5.2 Demographic data analysis 
The demographic questionnaire was coded for data recording. Frequency tables and a 
scatter plot with linear regression were used to present data. Data was then summarised 
in tables. The correlation coefficient according to Pearson’s correlation and the t-test was 
used to describe demographic data and its relation to vitamin D status. 
 
 
2.5.3 Anthropometric data analysis 
The anthropometric data was interpreted and classified according to the following 
variables (Table 2.4) and data capture sheet Addendum B was used. Mean, minimal and 
maximal values and standard deviation (SD) were used. Data was presented in a table 
and in bar charts. The Pearson correlation coefficient was used to determine correlation 
with vitamin D status. 
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Interpretation and Classification Calculation / Equation 




Classification BMI Disease Risk 
Underweight <18.50 Increased risk 
Normal weight 18.50–24.99 Least risk 
Overweight 25.00–29.99 Increased risk 
Obese 
   Class I 
   Class II 









Very high risk 
Extremely high risk 
 
Formulae: 
BMI = weight / (height)² 
 
Weight in kilograms 













Females: ≥ 80cm Females: ≥ 88cm 




2.5.4 Skin-type data analysis 
Skin-type classification of the population was done according to the Fitzpatrick Skin 
Phototype Classification (Table 1.3). Frequency and percentage values were used to 
describe skin-type data. Data was presented in tables and bar charts. Mean values were 
used to describe vitamin D status according to skin type. One-way ANOVA tests were 
used to compare skin type to vitamin D levels. Line graphs were used to present data. 
 
 
2.5.5 Sun exposure (calculated sun index) data analysis 
Data was grouped and analysed according to calculated sun index. The median and 
interquartile ranges were used as data was skewed. Data was presented in tables, box 
plot graphs, scatter plot and receiver operating characteristic (ROC) curve. Spearman’s 
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rank correlation coefficient was used between calculated sun index and vitamin D status to 
indicate correlation. 
2.5.6 Vitamin D oral intake data analysis 
Oral intake of vitamin D was grouped and analysed according to average daily intake and 
compared with vitamin D status. Mean, minimal and maximal levels were mentioned; 
however median and interquartile ranges were used as data was skewed. Oral intake was 
correlated with vitamin D status. Data was summarised and presented in tables and in a 
bar chart. Spearman’s rank correlation coefficient was used between oral vitamin D intake 
and vitamin D status to indicate correlation. 
 
 
2.5.7 Biochemical data analysis 
Vitamin D status data was used, interpreted and classified according to variables 
presented in Table 2.5. Mean and standard deviation were used to describe data. A chi-
square test was used to compare pre-operative values with post-operative values.Data 
was presented in tables, box plot figures, scatter plots, and a pie graph. 
 
Table 2.5: Biochemical Measurements and Reference Values 
Biochemical Measurement Interpretation and Classification
2,3,6,8,9,24,34,37,86
 
25-hydroxyvitamin D [25(OH)D] 
 
Undetectable:  <5ng/ml (12.5nmol/l) 
Vitamin D deficiency: <20ng/ml (<50nmol/l)  
Vitamin D insufficiency:  20–30ng/ml  (50–75nmol/l) 
Sufficient vitamin D:      >30ng/ml  (>75nmol/l)  




2.6 Ethical and Legal Aspects 
Ethics approval was obtained from the Health Research Ethics Committee of Stellenbosch 
University (S13/10/187). The protocol and ethics approval from Stellenbosch University 
were submitted to the Netcare Research Committee, a subcommittee of the Academic 
Advisory Board within Netcare, for approval. Approval was granted by Netcare (UNIV-
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2014-0011).The hospital manager of Mulbarton Hospital granted permission for the study 
as part of the Netcare approval process.  
 
 
2.6.1 Informed consent 
Autonomy was upheld by means of a consent form (Addendum A). All participants 
completed a consent form where research aims and details of the study were explained. 
The consent form included permission to participate in the study, answer questionnaires, 
be measured and weighed, and for a blood sample to be taken for vitamin D analysis. 
Participation was stated as voluntary and all collected data was treated as private and 
confidential at all times. All patient data was stored in the private offices and on the private 
computer of the investigator. Only the investigator, research supervisors and statistician 
had access to the data. 
 
Confidentiality and privacy were ensured at all times. All measurements and interviews 
were done in a private area. All data was handled confidentially. No names were attached 





















































3.1 Study Population 
During the baseline phase of the study period (8 April–2 September 2014), 167 
orthopaedic surgical patients at Mulbarton Hospital were on the theatre lists. Of these, 21 
were excluded owing to age and language, and a further 79 were excluded owing to 




Figure 3.1: Patient Recruitment Flow Diagram 
 
The mean timeframe for follow-up (round 2) was 78 days (SD 25; minimum 50 days and 
maximum 120 days) post-operative. Sixty-six percent of the study population was white, 
15% black, 13% coloured and 6% Indian. Of these patients, 23 (34%) returned for follow- 
up data collection. Patients were lost to follow-up owing to lack of interest, unavailability, 
not appearing for follow-up appointments, appointments not correlating with doctors’ 
appointments, and transport problems.  
Total Population 
Group n=167 
FINAL       
Sample Size: n=67 
Excluded: n=79:  
Outside Recearcher available 
timeframe - n=48  
Cancelled Surgeries - n= 7 
Duplicate Patients - n=2 
Declined Participation - n=22 
 
Exluded Total: n=21 
  <18 years old - n=13 
  >75 years old- n=7 
  Language - n=1 
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3.1.1 Demographic data 
The demographics of the orthopaedic surgical patients included in the study are 
summarised in Table 3.1. Of the 67 patients, 32.8% were male and 67.2% were female. 
The mean age of the study participants was 50.94 (SD 12.32) years (range 20 to 74 
years). Ninety-one percent were younger than 65 years and 9% older than or equal to 65 
years of age. The vast majority of the patients could understand either English or Afrikaans 
as their first or second language. All patients were admitted for elective surgeries, with the 
bulk of surgeries being minor surgeries (88.1%) (Table 3.1). 
 
Table 3.1: Demographic Characteristics of Patients 
Patient Demographics n (%) n (%) 










Language First Language 
English 40 (59.7%) 
Afrikaans 18 (26.9%) 
isiZulu 4 (6%) 
Other 4 (6%) 
isiXhosa1 (1.5%) 
Second Language 
English 26 (38.8%) 
Afrikaans 32 (47.8%) 
Other 6 (9%) 
Portuguese 2 (3%) 
isiXhosa1 (1.5%) 
Type of elective surgery Minor Surgery 59 (88.1%) 
Foot 13 (19.4%) 
Hand 13 (19.4%) 
Shoulder 13 (19.4%) 
Knee Scope 11 (16.4%) 
Elbow 4 (5.9%) 
Hip 3 (4.5%) 
Leg 1 (1.5%) 
Other 1 (1.5%) 
Major Surgery 8 (11.9%) 
Knee 6 (9%) 
Hip 2 (3%) 
SD = Standard Deviation 
 
 
3.1.2 Chronic disease profile of study population 
Self-reported chronic diseases (Table 3.2) of the study population were identified on the 
demographic questionnaire (Addendum C). Thirty-five participants (52.2%) of the study 
population identified one or more chronic conditions and 32 participants (47.8%) had no 
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chronic condition. The two most prevalent chronic conditions found were 
hypercholesterolemia (n=19, 28.4%) and hypertension (n=15, 22.4%). 
Table 3.2: Chronic Conditions of Study Population 
Chronic Condition n % 
Hypercholesterolemia 19 28.4 
Hypertension 15 22.4 
Thyroid 12 17.9 
Diabetes Mellitus 7 10.4 
Arthritis 5 7.5 
Receiving hormonal replacement therapy 4 6 
Asthma 4 6 
Ulcer 3 4.5 
Gout 3 4.5 




3.1.3 Smoking habits of study population 
The majority of the study population did not smoke at the time of data collection (n=51, 
76.1%),while 9 (13.4%) had previously smoked. Of the current smokers (n=16, 23.9%), 6 
(37.5) smoked 10 or fewer cigarettes per day. Most of the smokers (n=13, 81%) had been 
smoking for more than 10 years (Table 3.3). 
 
Table 3.3: Smoking habits of the Study Population 
Smoking Habit n (%) 
Smoker 16 (23.9%) 
Non-smoker 51 (76.1%) 
Previous smoker 9 (13.4%) 
Smoking > 10 years 13 (81%) 
Smoking < 10 years 3 (9%) 
Smoking > 10 cigarettes/day 10 (62.5%) 
Smoking ≤ 10 cigarettes/day 6 (37.5%) 
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3.1.4 Anthropometric data of the study population 
The mean weight of the males (n=22) was 94kg (SD 19) with a minimum of 65.8kg and 
maximum 148.3kg. For the females (n=45) the mean weight was 84kg (SD 26) with a 
minimum and maximum weight of 48.7kg and 151.6kg respectively (Table 3.4). 
 
Table 3.4: Anthropometric Data of the Study Population 
 Gender 
Male (n=22) Female (n=45) 
Mean SD Min Max Mean SD Min Max 
Height (m) 1.80 0.10 1.61 1.86 1.60 0.10 1.49 1.75 
Weight (kg) 94.0 19.0 65.8 148.3 84.0 26.0 48.7 151.6 
Waist (cm) 103.3 14.6 84 145 94.9 16.8 69 132 
BMI (kg/m²) 30.5 6.1 20.8 47.3 31.7 8.9 18.0 51.8 
SD: Standard Deviation 
Min:  Minimum 
Max:  Maximum 
BMI:  Body Mass Index 
 
The mean BMI of both the males and females fell in the obese category (30.5kg/m2 (SD 
6.1), with a minimum of 20.8kg/m2 and maximum of 47.3kg/m2 for males and 31.7kg/m2 
(SD 8.9), with a minimum of 18.0kg/m2 and maximum of 51.8kg/m2 for females. In this 
population, 86.4% of the males were overweight, of whom 36.4% were obese, and 71.1% 
of the females were overweight, of whom 46.7% were obese (Figure 3.2). Only 2.2% (n=1) 
of the females in the study population were underweight (BMI <18.5kg/m2). 
 
 




BMI : Body Mass Index 
Figure 3.2: BMI Classification of the Study Population 
 
Mean waist circumference of the males was 103.3cm (SD 14.6) and for the females, 
94.9cm (SD 16.8). More than 40% (n=9) of the males had a waist circumference >102cm 
(substantially increased risk) and more than half (55.8%) (n=25) of the females had a waist 
circumference >88cm (substantially increased risk). Figure 3.3 depicts the spread of 









































BMI Classification (kg/m2) 
Males
Females




Figure 3.3: Waist Circumference Classification of the Study Population 
 
 
3.1.5 Skin-type classification of study population 
The skin-type classification of the study population according to the Fitzpatrick Skin 
Phototype Classification (Table 1.4) showed that the majority of the population were Type 
FZ II and Type FZ III (n=24, 35.8% and n=20, 29.9%) respectively, with FZ I and FZ VI  
having only n=1 (1.49%) each. Figure 3.4 depicts the spread of patients according to the 
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Figure 3.4: Fitzpatrick Skin Phototype Classification of the Study Population 
 
 
3.1.6 Sun exposure 
The average temperature in Johannesburg for the first period of data collection from April 
2014 – September 2014 was 19ºC, with an average minimum temperature of 12ºC and 
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20 15 26 
May 
 
20 15 26 
June 
 
17 8 23 
July 
 
15 6 21 
August 
 
18 10 23 
September 
 
24 17 28 
Average  
 
19 12 25 
Daily, clear and sunny 




3.1.6.1 Pre-operative sun exposure (calculated sun index) 
The median calculated sun index value of the pre-operative group (n=67) was 0.715; the 
25th percentile value was 0.358 and the 75th percentile value was 2.075. The maximum 
value recorded was 10.25 and the minimum value was 0, owing to the use of sunblock and 
clothing. Sixteen patients were recruited in April, 8 in May, 13 in June, 5 in July, 21 in 
August and 4 in September. Sun exposure was similar during the months of May and July 
and was at its highest for the month of June. Lowest sun exposure was recorded during 
August (Figure 3.5). 
 




*Very high calculated sun index of 10.25 in April 
ºHigh calculated sun index of 4.95 in April           
*High calculated sun index of 2.94 in August          
 ºHigh calculated sun index of 2.31 and 2.09 in August 
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3.1.6.2 Post-operative sun exposure (calculated sun index) 
The median calculated sun index value was 0.715, the 25th percentile value was 0.385 and 
the 75th percentile value was 1.94.  This indicates the same median sun exposure level in 
the post-operative group as in the pre-operative group, with slightly lower sun exposure on 




*Highest value  
ºHigh outlying values 
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3.1.7 Vitamin D oral intake pre-operatively 
3.1.7.1 Vitamin D supplementation intake 
Pre-operatively only 21% (n=14) of the study population took vitamin D supplementation. 
The median intake of the 14 subjects was 400 IU/day, with a minimum intake of 200 
IU/day and a maximum intake of 1000 IU/day.  
  
 
3.1.7.2 Vitamin D food intake 
Pre-operatively the median oral daily intake of vitamin D from food was 195 IU, with a 
minimum intake of 24 IU and a maximum intake of 511 IU. With supplementation added to 
food intake, the daily values increase marginally to 202 IU(Table 3.5).  
 
Table 3.6: Vitamin D Intake (IU) Pre-Operatively 
Vitamin D intake: Oral and Supplementation 
IU (International Units) 












Minimum 24 200 24 
Maximum 511 1000 1227 
Percentiles 25 142 400 142 
50 195 400 202 
75 266 400 284 
 
 
The Vitamin D intake from individual food sources ranged from 0 IU (cod liver oil and milk 
powder) to 109.8 IU (egg, whole) pre-operatively and 0 IU (cod liver oil) to 125.8 IU (egg, 
whole) post-operatively. Egg in both cases was the major source of vitamin D intake 
(Figure3.7). 




































   Vit D 
   Intake 




   Food Item 
                                                    Figure 3.7: Vitamin D Intake from Food Sources 
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3.1.8 Vitamin D status 
3.1.8.1  Vitamin D status pre-operatively 
The mean vitamin D status (25(OH)D) of the study population was insufficient at 
26.0ng/mL (SD 9.6), with a minimum of 10.0ng/mL and a maximum of 54.0ng/mL. Thirty-
five point eight percent (n=24) had insufficient vitamin D levels and 29.9% (n=20) had 
deficient vitamin D levels; this means that 65.7% (n=44) did not have sufficient (>30ng/mL) 
vitamin D status. Only 34.3% (n=23) of the study population had sufficient levels of vitamin 
D(Figure 3.8). The average 25(OH)D values according to season for the warmer months 
(April, May, September) were 28.0ng/mL (insufficient) and for the colder months (June, 
July August) 26.4ng/mL (insufficient). 
 
When using the IOM cut off values for vitamin D status 70% (n=47) had sufficient 
(>20ng/mL) vitamin D status, 28% (n=19) had insufficient (12-20ng/mL) vitamin D status 
and 2% (n=1) had deficient (<12ng/mL) vitamin D status. 
 
 
3.1.8.2 Vitamin D status post-operatively 
The mean vitamin D status of the study population was insufficient at 28.2ng/mL (SD 
10.2), with minimum and maximum levels of 8.4ng/mL and 50ng/mL respectively. Thirty- 
nine point one percent (n=9) had sufficient vitamin D levels, while 39.1% (n=9) had 
insufficient vitamin D levels and 21.7% (n=5) had deficient levels. This means that 60.9% 
(n=14) did not have sufficient (>30ng/mL) vitamin D status (Figure 3.8). The average 
25(OH)D values according to season for the warmer months were 28.0ng/mL (insufficient) 
and for the colder months 28.3ng/mL (insufficient). 
 
 




Figure 3.8: Vitamin D Status Pre- and Post-Operatively 
 
Median 25(OH)D values (pre-operatively) for July peaked at 30ng/mL and then decreased 
















Vitamin D Status Post-
operatively 





Figure 3.9: 25(OH)D over the Data-Collection Period of April 2014–September 2014 
 
3.2 Relationship between 25(OH)D and Parameters Pre-Operatively 
3.2.1 The relationship between 25(OH)D and the demographic parameters pre-
operatively 
3.2.1.1 Age (pre-operatively) 
The relationship between age and 25(OH)D pre-operatively indicated a weak positive 
correlation coefficient according to Pearson’s correlation of r=0.249.This value is 
statistically significant (p=0.042). Linear regression (R2=0.062) indicates age as a weak 
predictor of 25(OH)D in this population group (Figure 3.10).  
 




Figure 3.10: 25(OH)D Pre-Operatively Correlated for Age 
 
3.2.1.2 Gender (pre-operatively) 
Pre-operative mean 25(OH)D for males (29.2ng/mL) was higher than that for females 
(24.5ng/mL), although not significantly so (p=0.057; t-test).  
 
 
3.2.1.3 Smoking (pre-operatively) 
Pre-operatively the smokers had a mean vitamin D value of 22.8ng/mL versus 27.04ng/mL 
for the non-smokers. The mean difference was -4.2ng/mL. This difference was not 
significant (p=0.126; t-test).  
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3.2.1.4 Skin classification (pre-operatively) 
Mean 25(OH)D as per the Fitzpatrick Skin Phototype Classification with minimum and 
maximum levels is summarised in Table 3.6. The mean values ranged from 15.6ng/mL 
(Type FZ VI) to 30.1ng/mL (Type FZ II). 
 
Table 3.7: Summery of 25(OH)D as per Skin Classification Pre-Operatively 


















Type FZ I 1 16.4 . . . 16 16 
Type FZ II 24 27.6 10.5 23.2 32.0 13 54 
Type FZ III 20 30.1 9.3 25.7 34.5 10 46 
Type FZ IV 9 22.6 7.7 16.7 28.6 13 32 
Type FZ V 12 20.3 5.6 16.7 23.9 13 34 
Type FZ VI 1 15.6 . . . 16 16 
Total 67 26.0 9.6 23.7 28.4 10 54 
 
 
One-way ANOVA was used to compare 25(OH)D levels of four different skin types (II – V). 
Skin types I and VI were omitted as they only had one subject per group. In the 
investigation to determine significant differences between the different groups, it was found 
that there was only a significant difference between group III and V (p=0.025). The mean 
difference was 9.8ng/mL, with group III having the highest values and group V having the 








Fitzpatrick Skin Phototype Classification 




3.2.2 Relationship between 25(OH)D and anthropometrics pre-operatively 
The Pearson correlation coefficient between 25(OH)D and BMI was r=0.042 and between 
25(OH)D and waist circumference r=0.112. There was no correlation between 25(OH)D 
and BMI (p=0.733) and waist circumference (p=0.365). 
 
 
3.2.3 Relationship between 25(OH)D and sun exposure (calculated sun index) pre-
operatively 
The Spearman's rank correlation coefficient between 25(OH)D and the calculated sun 
index was r=0.451, which indicates a moderate positive correlation (p<0.001). Linear 
regression (R2=0.103) indicates calculated sun index as a weak predictor of vitamin D 


























Figure 3.12: 25(OH)D Pre-Operatively Correlated for Calculated Sun Index Pre-Operatively 
 
 
3.2.4 Relationship between 25(OH)D status and vitamin D intake pre-operatively 
The Spearman's rank correlation coefficient between 25(OH)D and oral vitamin D intake 
was r=0.066 (p=0.598), for vitamin D supplementation, r =0.087 (p=0.483), and for total 
vitamin D intake, r=0.097 (p=0.434), indicating no correlation between 25(OH)D and oral 
vitamin D intake.  
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3.3 Relationship between 25(OH)D and Parameters Post-Operatively 
3.3.1 The relationship between 25(OH)D and the demographic parameters post-
operatively 
3.3.1.1 Age (post-operatively) 
The correlation coefficient according to Pearson’s correlation post-operatively was r=0.194 
(p=0.375), and was not statistically significant. 
 
 
3.3.1.2 Gender (post-operatively) 
Post-operatively the mean 25(OH)D for males was 33ng/ml and for females 27.1ng/ml. 
This difference was not statistically significant (p=0.316; t-test). 
 
 
3.3.1.3 Smoking (post-operatively) 
Using the One-way ANOVA test, there was no difference between smokers (n=2) and non-
smokers (n=21) post-operatively (p=0.602). 
 
 
3.3.1.4 Skin classification (post-operatively) 
Mean 25(OH)D ranged from 15.8ng/mL (Type FZ VI) to 31.8ng/mL (Type FZ II). Mean 
25(OH)D as per the Fitzpatrick Skin Photopype Classification is summarised in Table 3.7. 
With One-way ANOVA testing there was no statistical difference between the different skin 
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25(OH)D Post-operatively (ng/mL) 




Type FZ I 0 - - - - 
Type FZ II 13 31.8 9.8 15.7 51.6 
Type FZ III 6 25.1 11.2 8.4 36.3 
Type FZ IV 1 25.1 - 25.1 25.1 
Type FZ V 2 21.5 5.2 17.8 25.1 




3.3.2 Relationship between 25(OH)D and anthropometrics post-operatively 
The Spearman's rank correlation coefficient between 25(OH)D post-operatively and BMI 
was r=0.141 and for waist circumference r=0.045. There was no correlation between 
25(OH)D and anthropometrics post-operatively. 
 
 
3.3.3 Relationship between 25(OH)D and sun exposure (calculated sun index) post-
operatively 
The Spearman's rank correlation coefficient between 25(OH)D and the calculated sun 
index was r=0.397, but this was not statistically significant compared with the post-
operatively calculated sun index (p=0.413). 
. 
 
3.3.4 Relationship between 25(OH)D and vitamin D intake post-operatively 
The Spearman’s rank correlation coefficient between 25(OH)D and oral vitamin D intake 
was r=0.066, for vitamin D supplementation r = 0.087 and for total vitamin D intake 
r=0.097, indicating no correlation between 25(OH)D and oral vitamin D intake.  
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3.4 Pre-Operative Parameters in Relation to Post-Operative Parameters 
Twenty-three of 67 (34%) subjects returned for follow-up visits. Follow-up procedures were 
discussed in Section 2.4.1. 
 
 
3.4.1 Sun exposure (calculated sun index) pre-operatively and post-operatively 
The median sun exposure (calculated sun index) value for the pre-operative group that 
came for follow-up (n=23) and for the post-operative group (n=23) was 0.99 and 0.715, 
respectively, with a minimum value for the pre-operative group of 0.315 and a maximum 
value of 10.25. Minimum value post-operatively was 0 and maximum value 2.94 (Figure 
3.13). There was no significant difference between pre- and post-operative calculated sun 
index values (p=0.144).  
 
Retain null hypothesis: There is no statistically significant change in sun exposure 



































*High outlying values 




3.4.2 Vitamin D intake pre-operatively and post-operatively 
Median values for oral intake of vitamin D from food for the pre-operative group (n=23) 
was 226 IU, with a minimum and maximum intake of 64 IU and 454 IU. The 25th and 75th 
interquartile range values were 168 IU and 344 IU respectively. When total intake 
(supplementation and food) is calculated, the values increase marginally to 327 IU for the 
50th (median) percentile and 685 IU for the 75th percentile (Figure 3.14). 
 
The median oral intake of vitamin D from food for the post-operative group (n=23) was 240 
IU, with a minimum intake of 67 IU and a maximum oral intake of 669 IU. The 25th and 75th 
interquartile ranges were 101 IU and 354 IU respectively. With supplementation added to 
food intake, the values increase marginally to 340 IU for the 50th (median) percentile and 
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639 IU for the 75th percentile. There is no significant difference in vitamin D intake between 
the pre-operative and post-operative group (p=0.465) 
 
Retain null hypothesis: There is no statistically significant change in vitamin D intake after 











Figure 3.14: Vitamin D Intake Pre-Operatively (n=23) and Post-Operatively (n=23) 
 
 
3.4.3 25(OH)D pre-operatively and post-operatively 
The mean 25(OH)D of the pre-operative group was 28.7ng/ml (SD 11.6ng/mL) and for the 
post-operative group, 28.1ng/mL (SD 10.2ng/mL).  
 
The mean paired difference of the two groups was 0.48 (SD 5.03). There is no significant 
difference in 25(OH)D between pre-operative and post-operative groups (p=0.656). Using 
chi-square tests, there is no significant change in 25(OH)D status from the pre-operative to 
the post-operative state (p=0.549). 
 
Retain null hypothesis:  There is no statistically significant change in 25(OH)D after the 
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3.5 Calculated Sun Index Values and Vitamin D Status 
The clinical recommendation for sun exposure is 15–30 minutes of sun exposure on arms 
and legs 2–3 times per week. Sun exposure time per week = 1.5 hours. BSA (Body 
Surface Area): 0.14 (arms) plus 0.24 (legs) = 0.38 BSA. The calculated sun index for the 
clinical recommendation: 1.5 X 0.38 = 0.615.  
 
Pre-operatively 46.3% (n=31) of subjects had a calculated sun index value below the 
recommended value of 0.615; of these 19.4% (n=6) had sufficient vitamin D status and 
80.6% (n=25) had insufficient and deficient vitamin D status. Of the 53.7% (n=36) of 
subjects that had calculated sun index values above the recommended value of 0.615, 
52.8% (n=19) had insufficient and deficient vitamin D status (Table 3.9). 
 
Table 3.9:Cross-Tabulation of Vitamin D Status and Calculated Sun Index Pre-Operatively 
Vitamin D Status 
Calculated Sun Index 
Total < 0.615  ≥ 0.615 
 Sufficient 
>30ng/mL 
Count (n) 6 17 23 
%  19.4 47.2 34.3 
Insufficient and Deficient                  
≤30ng/mL 
Count (n) 25 19 44 
%  80.6 52.8 65.7 
Total Count (n) 31 36 67 
% 46.3 53.7  
 
 
Post-operatively 39.1% (n=9) of subjects had a calculated sun index value below the 
recommended value of 0.615; of these 22.2% (n=2) had sufficient vitamin D status, and 
77.8% (n=7) had insufficient and deficient vitamin D status. Of the 60.9% (n=14) of 
subjects that had calculated sun index values above the recommended value of 0.615, 
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Table 3.10:Cross-Tabulation of Vitamin D Status and Calculated Sun Index Post-Operatively 
Vitamin D Status 
Calculated Sun Index 
Total < 0.615  ≥ 0.615 
 Sufficient 
>30ng/mL 
Count (n) 2 7 9 
%  22.2 50 39.1 
Insufficient and Deficient                  
≤30ng/mL 
Count (n) 7 7 14 
%  77.8 50 65.7 
Total Count (n) 9 14 23 
% 39.1 60.9  
 
 
There is a statistically significant association between vitamin D levels and calculated sun 
index pre-operatively (p=0.017). One is more likely to have sufficient vitamin D levels if one 
has a sun exposure index of > 0.615, but almost equally likely to be insufficient or deficient 
if one’s index is > or < than the recommended levels of 0.615. Interpretation for post-




3.6 Predicted Calculated Sun Index Levels for Sufficient 25(OH)D 
Using the receiver operating characteristic (ROC) curve to determine sensitivity and 
specificity of the calculated sun index value to predict sufficient 25(OH)D, the 
recommended sun index value of 1.159 yielded sensitivity of 68.2% and specificity of 
56.5% (Figure 3.15). The area under the curve was 0.644 (p=0.054). 
 





















































It is well known that vitamin D is related to the prevention of rickets in children, but it is also 
critically important in the maintenance of calcium and bone metabolism throughout the life 
cycle. For adults, vitamin D deficiency can have subtle but important consequences for the 
musculoskeletal system.26  To the author’s knowledge, this is the first study of its kind done 
in South Africa investigating the vitamin D status of adult surgical orthopaedic patients in a 
private setting. Vitamin D status prevalence studies in South Africa in the adult population 
are limited. In this study, the parameters investigated were anthropometrics, sun exposure 
and vitamin D intake, and their relationship to vitamin D status pre- and post-operatively.   
 
 
4.1 Study Population Demographics 
A period of seven months was needed to recruit the 67 patients required for the study. The 
present study included adult females and males, where the majority of the group were 
younger than 65 years. Similar vitamin D prevalence studies have included only 
females,33,51 one study only males,86 and other studies, both genders.15,25 In the 
comprehensive review on worldwide status of vitamin D nutrition by Van Schoor and Lips, 
the age range of the populations varied from 18 to 85 years.25 This study represents a 
heterogeneous population including adult patients from various age groups, ethnic groups, 
language groups and a variety of minor and major elective orthopaedic surgeries. 
 
The two most prevalent chronic conditions in the population studied were 
hypercholesterolemia and hypertension. The chronic medications used in the treatment of 
these chronic conditions are not documented to have an impact on vitamin D status. A 
variety of medications, including anticonvulsants and medications to treat HIV/AIDS, can 
put patients at risk of vitamin D deficiency because these drugs enhance the catabolism of 
25(OH)D and 1,25(OH)2D.
98 These patients were not included in the study population. 
 
Almost a quarter of this study population were current smokers, which accords with the 
figures released by the Medical Research Council (MRC), where the prevalence of adult 
daily cigarette smoking in South Africa was recorded at 24.1% in 2004.123 More recent 
results published by the first South African National Health and Nutrition Examination 
Survey (SANHANES-1)(2013) reported current smoking by South African adults as 18.2%, 
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marginally lower than this study population.124 Smoking status in this study population did 
not seem to influence vitamin D status. 
 
In this study the mean weight of females (84.0kg) and males (94.0kg) was higher than the 
national average as reported by SANHANES-1 (72.2kg and 67.3kg respectively).124 The 
highest mean weights reported by SANHANES-1 were in the age groups 45–54 and 55–
64 for both genders (74.7kg and 71.8kg for males and 79.4kg and 77.2kg for females 
respectively).124 As the mean age of this study population was 50.9 years, the latter data is 
more comparable.  
 
In the analysis of worldwide mean BMI trends in populations from 1980 to 2008, the data 
showed an increase of between 0.4 and 0.5 kg/m2 per decade for males and females. 
Females from South Africa maintained their position in the top four BMI sub-regions (North 
America, North Africa and Middle East, and Southern Africa) compared with 1980.125 The 
current SANHANES-1 survey shows that the trend for increasing mean BMI in South 
Africa has continued, particularly among females.124 The mean BMI of this study for 
females (31.7kg/m²) and males (30.5kg/m²) was much higher than the SANHANES-1 data 
of South Africans overall (28.9kg/m² and 23.6kg/m² respectively).124 In South African 
females (SANHANES-1) the prevalence of overweight (24.8%) is similar to this study 
(24.4%), but the obesity rate (39.2%) is much higher in this study (46.7%). However the 
males in this study have much higher overweight (50%) and obesity (36.4%) rates than the 
average South African (20.1% and 10.6% respectively). In the SANHANES-1 data, the 
BMI of the older age groups was significantly higher for both females and males. The age 
groups 45–54 years, 55–64 years and 65 years and older had mean BMIs (31.7kg/m2, 
31.3kg/m2, 30.0kg/m2 for females, respectively, and 26.0kg/m2, 25.2kg/m2, 25.6kg/m2 for 
males, respectively).124 The average BMI classification of this study was obese class I 
(>30kg/m²); however the average BMI of the participants in other studies on vitamin D 
status done in the United Kingdom,98 Massachusetts in the United States,33 and Hawaii,15 
was all within normal range (18.5–24.9kg/m²). The typical orthopaedic surgical patient in 
26 hospitals across America, according to Tedeseco et al., was 65.5 (±14.5) years old. Of 
these, 20.2% (SD 15.4%) were obese.126 In a Swiss study, Zingg et al. noted that the 
number of patients undergoing orthopaedic surgeries, in this case total knee arthroplasty, 
was disproportionately high, with more than 42% of patients being obese127. These figures 
are more in line with the average obesity rates of this study (46.7%). 
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Overweight and obese patients have more surgical and post-operative problems and 
complications than patients with normal BMIs. Obese patients are also further more likely 
to experience micro-trauma injuries to their upper limbs than patients with a normal BMI, 
primarily because of motor control problems.128 A clear link has been established between 
osteoarthritis and obesity, owing to excess mechanical loads and the biological effects on 
the cartilage. The obesity effect is more apparent in the knee than the hip. A person with a 
BMI > 30 kg/m2 is 8.5 times more likely to need a joint replacement than someone with a 
normal BMI; this risk will increase to 18.7 times if the BMI is over 35kg/m² and to 32.7 
times if the BMI is over 40kg/m². Also, obese patients are operated on an average of 
ten years earlier than their normal BMI counterparts.128 The over-representation of 
overweight individuals among patients requiring general orthopaedic elective surgeries has 
also been seen in the study done by Böstman, where the population was 22–27% obese, 
compared with the general population of 16%.129 The correlation between BMI and 
25(OH)D is further explored later. 
 
A population level mean waist circumference that exceeds the recommended waist 
circumference cut-off (equal to or more than 102 cm in males and 88 cm in females) is 
indicative of a substantially increased risk of metabolic complications.121 According to 
SANHANES-1 data, the mean waist circumference for males (81.4cm) and females 
(89cm) was lower than the average of this study (103.3cm and 94.9cm respectively).   
SANHANES-1 data indicate that 10% of males had a waist circumference ≥ 102 cm, while 
approximately half of females had a waist circumference ≥ 88 cm. This is much lower than 
the data from this study (40.9% and 57.8% respectively). The review article by Parratte et 
al. on obesity in orthopaedic and trauma surgery does not include any data on waist 
circumference. BMI is the most common indicator for obesity used in the research.126-128. 
 
The Fitzpatrick Skin Phototype Classification used in this study has been validated87,89 and 
used in numerous studies.2,87-91 Other studies investigating vitamin D status in adults have 
not taken into account skin classification33 and/or ethnic group.114 Another study used 
reflectance colourimetry, where the Commission Internationalede l’Eclairage L scale was 
used that ranges from 0 (black) to100 (white) and represents a system created by the 
International Commission on Illumination to accurately represent human colour 
perception.15 
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4.2 Sun Exposure 
South Africa is a country on the most southern tip of the African continent, with coordinates 
of 30.0000° S, 25.0000° E. With regard to the South African population, most people 
(36%) live in a temperate/ mesothermal climate with dry winters, followed by 34% of the 
population that live in a temperate/ mesothermal climate, with significant precipitation in all 
seasons, while 21% of the population live in a semi-arid climate. Only a small percentage 
(1.6%) of South Africans live in a semi-arid/ steppe climate, while 0.6% of the population 
live in a tropical wet and dry / savannah climate.130 
 
In Johannesburg (coordinates: 26.2044° S, 28.0456° E) the mean sunlight hours range 
between 8 hours 18 minutes per day in April and 9 hours 12 minutes each day in 
September. There is an average of 3182 hours (72%) of sunlight per year (of a possible 
4383); the remainder of daylight hours (28%) are likely cloudy or with shade, haze or low 
sun intensity. The average is 8 hours 42 minutes sunlight per day. At midday in 
Johannesburg the sun is on average 63.3° above the horizon.132 As sunlight exposure is 
required for cutaneous vitamin D production, it is important to be cognisant of the sunlight 
hours, latitude, season and weather2 of the region of the study. Johannesburg, South 
Africa, has more than adequate daily sunlight hours for vitamin D production. 
 
In comparison, in Cape Town (coordinates 33.9253° S, 18.4239° E), the mean sunlight 
hours range from 6 hours 54 minutes per day in April to 7 hours 12 minutes per day in 
September. There is an average of 2993 (68%) hours of sunlight per year (of a possible 
4383); the remaining 31.7% of daylight hours are likely cloudy or with shade, haze or low 
sun intensity. The average is 8 hours 11 minutes of sunlight per day. At midday in Cape 
Town the sun is on average 55.6° above the horizon.94 Although Cape Town is situated 
further south of the equator than Johannesburg, it has enough sunlight hours. The vitamin 
D production in Cape Town during winter months might be lower due to the zenith angle of 
the sun. Cape Town sunlight hours were included as a matter of interest to demonstrate 
that the southern and northern parts of South Africa have very similar sunlight hours. 
Average daily temperatures in Johannesburg for the study period (April 2014 – September 
2014) were 19ºC versus  
17ºC for the same period in Cape Town.122 
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Sun exposure according to the calculated sun index was at its highest in the winter month 
of June 2014, where the average temperature in Johannesburg was 17ºC. Sun exposure 
was similar but lower than that of June during the months of May and July, when the 
average temperature in Johannesburg was 15ºC and 20ºC respectively. The colder winter 
months do not seem to influence sun exposure times. Participants might be outdoors for 
longer periods, but with less BSA exposed because of the colder weather. The lowest sun 
exposure was recorded in August; this might be due to the windy weather usually 
experienced during the month of August. Sun exposure then increased again during 
September, owing to the warmer weather (average 24ºC).122 
 
Rosso et al. documented a statistically significant increase in risk of squamous cell 
carcinoma (SCC) when sun exposure exceeded the threshold of more than 70 000 
accumulated hours of sun exposure in a lifetime.115 This can be calculated in a 70-year-old 
individual as 1000 hours per year; thus 19 hours 10 minutes per week or 2 hours 44 
minutes per day. Using the calculated sun index of this research project and assuming a 
sun exposure of arms (0.14 body surface area) and legs (0.24 body surface area), the sun 
index would be 19.18. This equates to very high sun exposure. Only one person in this 
study population had a calculated sun index above 7; this is much lower than the threshold 
for SCC risk. Basal cell carcinoma (BCC) showed a two-fold increase of risk for much 
lower sun exposure (8000–10 000 accumulated hours in a lifetime, thus 114–143 hours 
per year, thus 2 hours 12 minutes to 2 hours 44 minutes per week).110 Using the calculated 
sun index of this research project and assuming a sun exposure of arms (0.14 body 
surface area) and legs (0.24 body surface area), the sun index would be 0.83–1.04 for 
BCC. The 75thpercentile of this study population has a calculated sun index value of 2.075. 
This is higher than the threshold for BCC risk; however, the median sun index for the 
group is lower than the BBC risk threshold. There is always the question of increased 
cancer risk when higher sun exposure is recommended. According to the data on total 
lifetime sun exposure and cancer risk, it would seem that this population with its current 
levels of sun exposure is not at higher risk of developing skin cancer. According to 
Amstrong et al., there is a strong correlation between skin cancer and early childhood 
sunburn episodes.108 Childhood sun exposure was not recorded in this study population. 
Sun exposure guidelines and risk of skin cancer remain areas that need further 
investigation. 
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A novel approach to sun exposure was used in this study where time spent outdoors 
(hours per week) and body surface area exposed (percentage expressed as a decimal) 
were used as a calculated sun index. A similar method was used by Binkley et al., where 
skin colour was measured by reflectance colourimetry with a scale ranging from black (0) 
to white (100); added to this, a sun exposure index was used to determine amount and 
duration of skin sun exposure where subjects depicted their usual amount of skin exposed 
on a diagram. The rule of nines was used to calculate skin sun exposure.15, 86 This number 
was then multiplied with reported weekly sun exposure hours.15 The principles of this 
method were simplified and adapted for this study. Another method used in the study by 
Salamone et al. used a sunshine score that focused on time spent outdoors (little=1 and 
frequent=2) and the amount of sunlight exposure received (low=1 and high=2). A sunshine 
score, calculated as the sum of these two responses, was then classified as low (total =2) 
or high (total 3 or 4). A sunlight exposure score was added to this where a score between 
0 and 9 was allocated according to time spent outdoors in last week, degree of skin 
exposure, sunblock use, and travelling.33 
 
A calculated sun index (used in this study) value of 0.615 would express the clinical 
recommendation2,16,31,35  for sun exposure. This would mean 30 minutes of sun exposure 
three times per week (total time 1.5 hours/week) on arms (0.14 body surface area) and 
legs (0.24 body surface area).This recommendation should be obtainable during lunch 
hours and/or weekends, as South Africa is well known for its sunny weather and outdoor 
lifestyle. 
 
Pre-operatively the median calculated sun index for the study population was 0.715; thus 
50% of the study population had higher sun exposure than the clinical recommendation. 
The sun index value of 0.715 can be interpreted as 38 minutes of sun exposure three 
times per week (total time 1.88 hours) on arms (0.14 body surface area) and legs (0.24 
body surface area). The highest sun index recorded was 10.25, which indicates very high 
sun exposure. This means 3 hours 51 minutes of sun exposure seven times per week 
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Post-operatively the median calculated sun index for the study population was also 0.715, 
indicating the same median sun exposure as pre-operatively. The highest sun index value 
recorded during the post-operative follow-up was 2.94; this translates to 2 hours 35 
minutes of sun exposure three times a week (total 7.73 hours per week). 
 
In closing: this study population had higher sun exposure than the clinical recommendation 
in the literature, and with a latitude of below 37º, Johannesburg is ideally situated to 
provide adequate sunshine, even in winter months. This amount of sun exposure is not 
indicated as enough sun exposure to be classified as increased risk of skin cancer. 
 
 
4.3 Vitamin D Oral Intake 
The guidelines for daily requirements for vitamin D intake from the Endocrine Society37 
(1500–2000 IU/day) are used as reference in this study as the study population can be 
considered an ‘at risk’ group as the participants of the study population were hospitalised 
for elective orthopaedic surgeries. The Institute of Medicine (IOM) adequate intake of 
vitamin D at 400–600 IU/day is recommended for a healthy population.79 
 
Blalock et al. found that the mean differences between estimating vitamin D from a short 
screening food frequency questionnaire versus using a seven-day food diary was 47 
IU/day. The positive predictive value of the short screening food frequency questionnaire 
in identifying persons with low vitamin D intakes was 100.0%.117 Using the adapted short 
food questionnaire for vitamin D (Addendum G) that consists of the food available in South 
Africa with the highest vitamin D content (19 food choices), the average daily vitamin D 
intake was calculated. The average vitamin D intake from the individual food sources 
indicates that the most common source of vitamin D in the study population was eggs 
(average intake of 109.8 IU/day), followed by margarine (12.7 IU/day), butterfish (11.5 
IU/day), health bars (11.4 IU/day) and FutureLife® cereal (10.5 IU/day). With these results 
of vitamin D intake from food sources, extra groups might be considered to add to the at- 
risk list in South Africa. These are individuals with egg allergy who avoid eggs, as well as 
vegetarians and specifically ovo-vegetarians, as the two main sources of vitamin D from 
food in this context are eggs and fish. 
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The median daily oral intake from food sources of the study population was 195 IU; this is 
only 13% of the lower range of the daily requirements of the Endocrine Society of 1500–
2000 IU/day.18,37 The 25th and 75th interquartile ranges of 142 IU and 266 IU respectively 
were also far below the recommended intake of the Endocrine Society. When vitamin D 
supplementation intake was added to oral intake, the median intake only increased to 202 
IU/day; this is 13.5% of the lower range of the recommended intake of the Endocrine 
Society. It is clear that this population is not nearly attaining oral vitamin D intake in 
relation to these guidelines. When comparing the daily oral intake with the IOM guidelines 
(400–600 IU)18 developed to meet the needs of at least 97.5% of the population according 
to age,79 the intake is still only approximately 50% of the recommendation. 
 
When comparing study data with the international findings of Wacker and Holick, the mean 
daily vitamin D intake from food and food plus dietary supplements from these two large 
surveys, the Continuing Survey of Food Intakes by Individuals (CSFII 1994–1996 and 
1998) and the Third National Health and Nutrition Examination Survey (NHANES III USA 
1988–1994), intake ranges from just more than 100 IU–350 IU for both studies.18 These 
intake values are also far below (17%–58%) the recommendation of the IOM of 400–600 
IU for adults and the Endocrine Society recommendation of 1500–2000 IU per day (6%–
23%).18,37 American oral intake data for vitamin D is slightly higher than the findings in this 
study from South Africa; these differences can be attributed to the fact that South Africa 
has very few food items fortified with vitamin D.12 
 
It is very clear that the oral intake of vitamin D from food alone (as the body’s sole source) 
will not be enough to reach adequate 25(OH)D. The response increment of 25(OH)D is   
1–0.7ng/mL/100 IU.18,34,84 With vitamin D intakes of around 200 IU, 25(OH)D contribution 
from oral intake is only around 2ng/mL. 
 
A small proportion of the study population used supplementation (21%). The median 
intake was 400 IU/day which is 27% (only supplementation) of the lower range of the 
Endocrine Society daily requirement of 1500–2000 IU.18,37 The maximum intake from 
supplementation was 1000 IU/day, only 67% of the daily requirements. The source of the 
supplementation was multivitamins (Pharmaton, Centrum and Biogen containing 400 IU 
vitamin D each); calcium supplements (Menacal7, BCalD and Caltrate containing 400 IU 
vitamin D each); Staminogro (containing 150 IU/tablet); and a pure vitamin D supplement 
(Solal) containing 500 IU/tablet. The majority of vitamin D came from combination 
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supplements like multivitamins and calcium supplementation. Vitamin D supplementation 
from pure vitamin D supplements was rare in this study group. At the time of data 
collection (April 2014 to November 2014), more than half of the vitamin D supplements 
available today were not yet on the market in South Africa. Most vitamin D supplements 
contained 500 IU or less. Table 1.6, the list of supplemental sources of vitamin D in South 
Africa, was updated in November 2016. The majority of vitamin D supplements containing 
more than 500 IU only became available recently in 2016 as supplements. The guidelines 
with regard to the quality, safety, dosage and efficacy requirements for the registration of 
health supplements are published by the Medicines Control Council (MCC) of South 
Africa. These guidelines have recently been updated. The allowable levels and claims for 
vitamins are contained in the MCC Complementary Medicines – Health Supplements 
Quality, Safety and Efficacy document, Version 2, published in June 2016. The maximum 
vitamin D dose that is allowed in an over-the-counter supplementation is 1 000 IU.101 
Vitamin D doses higher than 1 000 IU are available on prescription as 2 000 IU or 5 000 IU 
by Metagenics® (not scheduled) or 5 000 IU /ml oil or 50 000 IU tablet by Lennon 
(Schedule 3). 
 
Deficiencies can be addressed by high dose supplementation of 50 000 IU once a week 
for eight weeks, followed by 50 000 IU every 2–4 weeks thereafter or 6000 IU daily for 
eight weeks followed by maintenance therapy of 1500–2000 IU/day as recommended by 
the Endocrine Society.37,81 The risk of toxicity is very low, as no toxicity has been reported 
with supplementary doses of 10 000 IU or less per day.35 
 
 
4.4 Vitamin D Status 
In this study, vitamin D insufficiency was defined as vitamin D levels between 20 and 
30ng/mL and vitamin D deficiency was defined as vitamin D levels below 
20ng/mL.2,3,6,8,9,14,16,18,37,50 There is no absolute consensus as to what the normal range for 
vitamin D should be; in global studies values of 20ng/mL are often indicated as sufficient 
and those below 20ng/mL as deficient.18,24,132 Holick et al. reported that a dot plot graph of 
serum 25(OH)D as a function of PTH levels provides insight into what vitamin D levels 
should be. It was observed that the PTH levels began to plateau when 25(OH)D levels 
were between 30 and 40ng/mL.3 Heaney and Holick measured intestinal calcium 
absorption in woman with 25(OH)D levels of 20ng/mL and 32ng/mL; they reported a 45–
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65% increase in calcium absorption at the higher levels.84 The preferred level for 25(OH)D 
is now recommended by many experts to be >30ng/mL.3,8,18,84 With this in mind, deficiency 
was defined as <20ng/mL, insufficiency as 20–29ng/mL and sufficient as 30–100ng/mL for 
the purpose of this study. There have been numerous different guidelines used over the 
years to define vitamin D deficiency, ranging from < 5ng/mL24 to 20ng/mL. These low 
ranges complicate interpretation of older data when deficiency is defined at such low 
values. A previous vitamin D classification of ‘sufficient’ might have to be reclassified as 
‘insufficient’ or ‘deficient’. It is thus recommended to always refer to the actual value of 
serum 25(OH)D when citing research.  
 
Deficiency is highly prevalent in the Middle East (mean values of 12.8ng/mL in Turkish 
women), Asia (mean values of 14.4 in Chinese adolescent girls in Beijing), and India 
(mean values of 12ng/mL in hospital staff).24 A moderate to poor25(OH)D is also 
commonly seen in Africa (9.4ng/mL in Ethiopian men and women; 17ng/mL in non-veiled 
woman in Tunisia),9 in part owing to their dark skin types. In Europe, when examining 
25(OH)D levels lower than 20ng/mL, deficiency ranges from 40–80% in the various adult 
age groups.24 Vitamin D status appears to be much better in North America, where vitamin 
D deficiency is not so common, but vitamin D insufficiency (20–30ng/mL) is still common. 
Most studies are done on specific populations, such as the elderly, residents of institutions, 
the disabled, specific ethnic groups, populations with certain dress customs, and other 
high-risk groups.18,24,27 Based on all these findings, it has been estimated that up to one 
billion people worldwide are vitamin D insufficient or deficient. 
 
Pre-operatively the mean vitamin D status of this study population was classified as 
insufficient (26ng/mL, SD 9.6). The cumulative percentage of insufficient (35.8%) and 
deficient (29.9%) is 65.7% (<30ng/mL). There is little data available on orthopaedic 
patients in Africa and South Africa. In 1978, Pettifor et al. recorded mean serum 25(OH)D 
as 17.6ng/mL in South African patients with hip fractures: the population was an elderly 
population with a mean age 72,7± SD 13 years.27 Coussens et al. recently reported values 
of <20ng/mL in  4–16%(summer) and  64–70%(winter) of participants in different ethnic 
groups respectively (Xhosa and Cape Mixed ancestry).133 In a review done by Abhimanyu 
et al. on 25(OH)D and tuberculosis in South Africa, it is apparent that Asian-Indians are 
vitamin D deficient (16ng/mL), blacks are insufficient (28ng/mL), and whites are sufficient 
(34ng/mL). All values are mean values and deficiency, insufficiency, and sufficiency are 
defined as <20, 20-29 and 30-100ng/mL respectively.134 Comparative global data show 
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Indonesians to be insufficient (23.6ng/mL), South Indians deficient, (8ng/mL), West 
Africans insufficient (27.6ng/mL), East Africans sufficient (46ng/mL), Dutch deficient 
(19.6ng/mL), Germans deficient (18.4ng/mL), French insufficient (20ng/mL) and British 
deficient (11.6ng/mL).134 These differences are most likely due to a mixture of skin colour, 
clothing, sun exposure, vitamin D intake, climate and latitude, inter alia. 
 
In a study done in Israel, the prevalence of hypovitaminosis D was 26.7%, with 
hypovitaminosis defined as <15ng/mL,114 much lower than the current cut-off values for 
deficiency (<20ng/mL). This might explain why deficiency levels were lower in the Israeli 
study than in the current study. The population group in the Israeli study comprised 
patients admitted to an internal medical ward with no known risk factors for 
hypovitaminosis D.114 The levels of vitamin D deficiency and insufficiency found in this 
current study were probably higher than expected because in Johannesburg, South Africa, 
there is abundant sunshine, even in the winter months. The findings might be in part 
explained by low vitamin intake from food, low supplementation use, low sun exposure, 
high BMI, and skin colour. 
 
Post-operatively the mean 25(OH)D of this study population was insufficient (28.2ng/mL, 
SD 10.2). The cumulative percentage of insufficient (39.1%) and deficient (21.7%) was 
60.8%. The difference between pre- and post-operative mean values is not significant. 
These levels of insufficiency might warrant supplementation or increased sun exposure. 
Supplementation is becoming more affordable as new supplements enter the market. 
Food fortification is a simple strategy that is also low cost, but great care should be taken 
in choosing the food vehicle and level of fortification to target the correct population 
groups. Consumer awareness of fortification is also important when targeting a specific 
population group.  
 
When IOM vitamin D status guidelines are used the cumulative percentage of insufficiency 
and deficiency was 30%, and sufficient levels were 70%. The IOM states that practically 
all persons, that is 97.5% of the general population, are assured bone health when serum 
levels of 25(OH)D are >20 ng/ml. When the recommendation of >16ng/mL is used then 
14% (n=9) of the study population have deficient vitamin D status. The IOM states that 
about half the general population are assured bone health when serum levels of 25(OH)D 
is >16 ng/ml. 
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International data available on post-surgery vitamin D status mostly relates to gastric 
bypass surgery and is thus not comparative data, as morbidly obese patients have been 
reported to present with vitamin D insufficiency.103 In the current study, median values of 
25(OH)D were 28ng/mL in April, then decreased in the first two months of winter (May and 
June), were higher in July, decreased in August, and then were higher again in 
September. In June and July the widest ranges of 25(OH)D levels were recorded: from 
>10ng/mL to <50ng/mL. The current study was conducted mostly over autumn, winter and 
early spring. Because the whole-body half-life of 25(OH)D from sun exposure can be as 
long as 6–8 weeks,45 25(OH)D status can still be quite high at the beginning of winter. It 
can also be speculated that vitamin D might be higher later in winter because winter 
daytime temperatures in Johannesburg are very pleasant and there is little to no cloud 
cover; outdoor activity can therefore still occur. August is known as the windy month in 
Johannesburg; outdoor activity might thus decline, and September sees the beginning of 
spring with higher temperatures and more outdoor activities.  
 
 
4.5 Relationship between 25(OH)D and Parameters Pre- and Post-Operatively 
Pre-operatively the correlation between age and 25(OH)D in this study population was not 
significant. Ageing is documented as a risk factor for vitamin D insufficiency and 
deficiency.2,6,16,19,24 Some of the highest 25(OH)D levels were found in two subjects over 
70 years of age (54ng/mL and 51.6ng/mL). Granted these two subjects also scored the 
highest with regard to their calculated sun index, so this was to be expected to some 
degree. Mean 25(OH)D was higher in males (29.2ng/mL) than in females (24.5ng/mL), 
although not significantly so (p=0.057). Post-operatively there was no correlation with 
25(OH)D and age, probably because of the small sample size.  Although the mean 
difference of 25(OH)D between males and females increased post-operatively from 
4.7ng/mL to 5.8ng/mL, it was still not statistically significant (p=0.316). In another study114 
there was also no significant difference in 25(OH)D, with slightly higher levels in males 
than in females.  
 
Pre-operatively non-smokers (27ng/mL) had slightly higher 25(OH)D levels than smokers 
(22.8ng/mL), but this did not reach significance (p=0.126). Post-operatively there was no 
statistically significant difference between smokers and non-smokers. It should be noted 
that the post-operative sample size was very small (n=23) and only two participants 
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smoked. Lange et al. also found no significant association between smoking and 25(OH)D 
levels (p=0.2). In the Lange study, smoking was significantly and inversely associated with 
lung function (p=0.0001). Vitamin D deficiency also had a negative effect on lung function, 
suggesting that vitamin D-deficient subjects that smoked the same number of cigarettes as 
vitamin D-sufficient subjects had lower lung function. This suggests that maintaining a 
sufficient vitamin D status may have a protective effect against the more rapid decline in 
lung function as seen in smokers.135 
 
Skin classification with the Fitzpatrick Skin Phototype Classification was used in this study 
as in many others,2,87-91 as it gives a more accurate description of the skin colour of the 
population than ethnic group classification alone, since people within different ethnic 
groups can have different skin tones. Pre-operatively vitamin D status according to skin 
type showed lowest mean 25(OH)D levels in skin type I (lightest) and skin type VI 
(darkest); however both these groups had only one subject so they were omitted from 
further analysis. Skin type III (white skin, burns minimally, tans well) had the highest mean 
25(OH)D values (30.1ng/mL; SD 9.4). This skin type will produce more vitamin D because 
the skin is lighter and tans moderately and gradually. This group may be less likely to 
avoid sun exposure extensively. Skin type V (brown skin, rarely burns, tans deeply) differs 
significantly  (p=0.025) from skin type III, as skin type V had the lowest25(OH)D mean 
level of the remaining skin types in the analysis. Thus the study findings are in line with the 
well-documented fact that skin pigmentation (darker skin) absorbs UVB radiation via 
melanin and thus produces less vitamin D.2,6,8,16,19,24,35 In the post-operative group (n=23) 
there was no difference (p=0.389) between the different skin types, probably owing to the 
small sample size. In this group, skin type II (white skin, always burns, minimal tan) had 
the highest mean 25(OH)D level (31.8ng/mL) and skin type V still had the lowest 
25(OH)DD level (21.5ng/mL). 
 
Obesity is a known risk factor for vitamin D insufficiency and deficiency as an increased 
BMI is related to decreased vitamin D status because vitamin D is sequestrated in fat 
stores.2,6,16,19,24,35 Fat stores can be an irreversible sink for vitamin D in obese individuals. 
Holick observed that obese subjects could exhibit increases in blood vitamin D 
concentrations of less than 50%, when compared with non-obese individuals, after 
supplementation.2 The mean BMI of this study population was 31.33kg/m2 (Obese Class I); 
however there was no correlation with 25(OH)D and BMI (pre-operatively). No correlation 
was found post-operatively between anthropometric measurements and vitamin D status. 
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A study conducted in bariatric surgery patients (Roux-en-Y gastric bypass surgery) 
[RYGBP]) investigating vitamin D status, found that more than 90% of the population 
screened had some sort of hypovitaminosis D (25.0% with insufficiency, 68.8% with 
deficiency). The average BMI of the bariatric group was >48kg/m2 (Obese Class III),115 
compared with 31.3kg/m2 of this study group. It is not clear at what level of BMI vitamin D 
insufficiency is more likely to occur.  
 
Pre-operatively a positive correlation (p<0.001) between calculated sun exposure index 
and 25(OH)D was found. Calculated sun index was a weak predictor of vitamin D status in 
this population group (R2=0.103). While there was a positive correlation pre-operatively, 
there was no correlation post-operatively between 25(OH)D and calculated sun exposure 
index. Again, this might be due to the small sample size of this group. It should be noted 
that as shown in previous research studies, high sun exposure does not necessarily 
guarantee sufficient vitamin D status (>30ng/mL). In the cohort of young adults in the 
Binkley et al. study, there was considerable variability in vitamin D concentrations even 
though abundant sun exposure was documented.17 Additionally, despite the amount of sun 
exposure, the 25(OH)D concentration did not exceed approximately 60ng/mL.15 In this 
regard it is acknowledged that human skin has the intrinsic capability to limit vitamin D 
production.2 It is definitely plausible that genetic differences are present in the quantity of 
vitamin D needed to continue optimal physiological function. Thus, it is probable that 
factors may exist which we do not yet fully understand that can limit skin production of 
vitamin D in response to UV exposure. It is important that we do not wantonly agree to the 
notion that vitamin D deficiency and insufficiency are solely due to too little UV exposure.15 
It seems self-evident from this and other studies that insufficient vitamin D status, as it is 
currently defined in the literature, could occur regardless of “more than adequate” sun 
exposure.2,15,86 Sun exposure in this and other studies took into consideration the use of 
sunscreen and body surface exposed to sunlight. The sun exposure calculated was 
without sunscreen, and protective clothing was taken into consideration.86 
 
The response increment for 25(OH)D is 1–0.7ng/100 IU.18,34,84 Pre-operatively the median 
vitamin D intake from food ranged from 24 IU/day to 511 IU/day. It seems very unlikely that 
vitamin D status can be maintained from food intake alone in this group. The response 
from vitamin D intake on 25(OH)D will only be 0.2ng/mL to 5.1ng/mL. Thus it is 
understandable that there is no correlation between 25(OH)D and oral intake in this study 
as intake was too low. When adding supplementation intake to the equation, the minimum 
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intake ranged from 24–1227 IU/day. The highest response to 25(OH)D from total intake 
will only be 12.3ng/mL, still deficient in meeting vitamin D sufficiency of 30ng/mL. Post-
operatively, vitamin D intake from food increases marginally from 67–669 IU per day. No 
correlation between 25(OH)D and oral intake in the post-operative group was noted. When 
adding supplementation intake to the equation, the intake was 67–1215 IU per day. The 
highest response to 25(OH)D from total intake will only be 12.2ng/mL, still not adequate in 
meeting vitamin D sufficiency of 30ng/mL.  
 
 
4.6 Pre-operative Parameters in Relation to Post-Operative Parameters 
One of the aims of this study was to determine if the orthopaedic surgical intervention 
would change sun exposure habits and thus impact on vitamin D status. It was found that 
the calculated sun index (thus sun exposure time and body surface area (BSA) exposed) 
did not change significantly from the pre-operative to post-operative period. It can be 
assumed that with major orthopaedic interventions such as hip replacement and back 
surgery, where the recovery period would be much longer and sometimes even include 
rehabilitation, there would be an influence on sun exposure habits after surgery as well as 
before surgery as patients might be immobile for extended periods of time. In this study 
population there were only 12% major surgeries included, and 88% minor surgeries that 
could have had an impact on the mobility of patients. The null hypothesis is thus retained 
that there is no statistically significant change in sun exposure after orthopaedic surgical 
impact compared with the pre-surgery sun exposure. In other major orthopaedic surgeries 
this might not be the case, as seen in patients with lumbar spinal stenosis where vitamin D 
status improved significantly after surgery (one year later) (p=0.017).136 In this study the 
short-term impact of the surgical intervention was not investigated. The authors 
hypothesised that decompression surgery improves physical function in patients with 
lumbar spinal stenosis, and the resulting improved physical function will increase serum 
vitamin D levels by preventing hypovitaminosis D resulting from high bone turnover caused 
by restricted mobility, increased sun exposure from improved walking ability, and 
subsequent improvement in nutritional status.136 In this study the long-term benefits were 
not explored as follow-up period was 78 days (SD=25). 
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In this study it has already been established that vitamin D intake from food and 
supplementation does not significantly influence 25(OH)D pre- and post-operatively. 
According to the data collected, the participants did not substantially increase their vitamin 
D food intake or supplementation intake post-operatively. The null hypothesis is thus 
retained that there is no statistically significant change in vitamin D intake after orthopaedic 
surgical impact compared with that prior to surgery. 
 
There was a very small mean paired difference in 25(OH)D between the pre-operative and 
post-operative group of 0.5ng/mL ± SD=5.03. It could be hypothesised that the 
orthopaedic surgical impact and accompanying recovery period might impact 25(OH)D 
negatively. This might be the case in major surgeries like hip replacements and back 
surgeries where mobility is impaired in the short term during recovery; however in the long 
term the reverse might also be true, where 25(OH)D improved post-operatively owing to 
better mobility.136 In this study population the null hypothesis is retained that there is no 
significant change in 25(OH)D after orthopaedic surgical impact and recovery compared 
with the pre-surgery status. This study could be repeated in a study population consisting 
of only major surgeries to determine if surgical intervention will impact the vitamin D status 
in the short and long term.  
 
The calculated sun index for the clinical recommendation16,31,35 of sun exposure to ensure 
adequate vitamin D as recorded in the literature equates to 0.615. In this study population 
(pre-operatively), 80.6% of the population with sun exposure less than the clinical 
recommendation was insufficient and deficient in vitamin D status. It is very important to 
also note that in the sub-group that had enough sun exposure according to the clinical 
recommendation (>0.615), only 47% had sufficient vitamin D. Just over half (53%) of the 
group with enough sun exposure according to the clinical recommendation still had 
insufficient and deficient vitamin D serum levels. Similar results were found in the post-
operative group where 78% of the group without enough sun exposure had insufficient and 
deficient vitamin D status and half of the participants had insufficient and deficient vitamin 
D status even with enough sun exposure (according to the clinical recommendation in the 
literature).Thus, even ample sunlight exposure does not guarantee adequate 25(OH)D for 
all persons, according to the currently accepted clinical recommendations. This implies 
that in this study and in the study of Binkley et al., the current clinical recommendation to 
allow sunlight exposure to the arms and legs (not face) and without sunblock for 15–30 
minutes two to three times a week between 11:00 and 15:00 in spring, summer and 
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autumn16,31,35 may possibly not ensure the production and synthesis of sufficient vitamin 
D.15 Dietary intake of vitamin D was not included in the Binkley study. 
 
 
4.7 Predicted Calculated Sun Index Levels for Sufficient Vitamin D Status 
When the ROC curve is used to predict a more favourable outcome for 25(OH)D and 
recommended sunlight exposure, a sensitivity of 68.2% can be achieved versus 53% with 
a calculated sun index of 1.159. The specificity will be 56.5%. If the same BSA exposure is 
used as in the clinical recommendation of the literature (arms and legs), the sun exposure 
time will double from 30 minutes to one hour. A calculated recommendation will then be 60 
minutes sun exposure to arms and legs three times per week, or 30 minutes six times per 
week on the arms and legs. This is double the current recommendation. Even then 
sufficient vitamin D status cannot be guaranteed as it is known that there are many other 
factors that influence 25(OH)D, such as age, skin tone, BMI, season, and latitude, inter 
alia. 
 
The fact that just more than a third of the participants in this study had sufficient levels of 
vitamin D is a worrying factor when it is taken into consideration that South Africa has 
abundant sunshine and that the median sun exposure of this study group does meet 
clinical recommendations. Oral intake of vitamin D is found to be very low and 
supplementation in this group is underutilised. This study group can be seen as an at risk 
group, as the mean BMI of the group is more than 30kg/m2 (obese) and all participants 
were scheduled for elective orthopaedic surgery. As the function of vitamin D in bone 
health is well documented, greater care should be taken in ensuring optimal vitamin D 
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5 CONCLUSION AND RECOMMENDATIONS 
5.1 Findings and Conclusions 
Vitamin D is well documented to be essential in guaranteeing skeletal health, and as new 
research emerges it is clear that it plays an important role in overall health. What is truly 
remarkable is that in this modern day and age, with advances in medicine, vitamin D 
deficiency has resurged in all population groups. The question also might be asked if we 
are only recognising the problem now? Vitamin D insufficiency can be very subtle and for 
this reason can go unrecognised by health professionals.  
 
This study aimed to shed some light on the current vitamin D status and factors influencing 
it in an orthopaedic surgical population in a private hospital in Johannesburg. In the current 
study sun exposure was slightly higher than the clinical recommendation; however this 
was not enough to guarantee adequate 25(OH)D levels (a third of the study population 
had insufficient levels and a third had deficient vitamin D levels). These high levels of 
vitamin D insufficiency were not expected in a country with such abundant sunshine all 
year round. These findings were relevant for light- and dark-skinned individuals. Oral 
intake of vitamin D from food and supplementation was also inadequate in terms of 
recommended daily intake. Not even a quarter of the current recommendations were met, 
as very few foods contain vitamin D and food fortification and supplementation is not 
common in South Africa. These parameters did not change significantly post operatively, 
thus it can be concluded that minor orthopaedic surgery will probably not influence pre-
operative vitamin D status and other habits of sun exposure and vitamin D oral intake to 
any extent. Recommended sun exposure to predict more favourable outcomes would be at 
least double the current clinical recommendation. 
 
In the current study age, smoking and BMI were not strong predictors of vitamin D status. 
Calculated sun index (sun exposure) was a moderately strong predictor of 25(OH)D. 
Subjects with a white skin that burns minimally but tans well had the highest 25(OH)D 
versus their darker counterparts with brown skin. Minor orthopaedic surgical interventions 
do not negatively influence patients’ sun exposure habits, vitamin D intake, and thus 
vitamin D status, but these patients seem to start off with lower than expected 25(OH)D 
levels and might be considered to be an “at risk” group as their mean BMI classification is 
obese and elective surgery is scheduled.  
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Standard vitamin D testing is still not recommended in the general population, with testing 
only warranted in at-risk groups. Current studies propose that more vitamin D may be 
needed than presently recommended. Where more sun exposure is not possible or is 
contra-indicated, vitamin D supplementation of 50 000 IU per week for eight weeks 
followed by 50 000 IU every two to four weeks thereafter or 6 000 IU daily for eight weeks 
followed by maintenance therapy of 1500–2000 IU/day as recommended by the Endocrine 
Society is advocated.37 This is a cost-effective and practical recommendation. 
 
This study clearly highlights the need for more specific guidelines to obtain optimal vitamin 
D status. These guidelines need to distinguish between different groups in terms of skin 
tone, sun exposure habits and at-risk groups, where different sun exposure guidelines 
might be needed. Skin protection against skin cancer should be kept in mind. Education 
regarding food sources rich in vitamin D should also be included in the multi-pronged 
approach. If these guidelines cannot be met, supplementation should be considered. This 
study indicates that the orthopaedic surgical population is an at-risk group that can benefit 
from a multi-pronged approach to improve vitamin D status. 
 
In this study, the null hypothesis is rejected where the hypothesis states that there is no 
statistically significant correlation between vitamin D status and age, vitamin D status and 
sun exposure, and vitamin D status and skin tone. The null hypothesis is retained where 
the hypothesis states that there is no statistically significant correlation between vitamin D 
status and gender, smoking, BMI, waist circumference, vitamin D intake and vitamin D 
supplementation. The null hypotheses were also retained where there was no statistically 
significant change in sun exposure, vitamin D intake, vitamin D supplementation, and 
vitamin D status after the orthopaedic surgical intervention.  
 
 
5.2 Recommendations for Future Studies 
Given the key roles that vitamin D plays in fractures, falls and orthopaedic pathways, this 
field of study deserves further attention. Testing and validating of the calculated sun index 
formulae tool could be suggested as a measure of sun exposure as the tool used in this 
study was a novel approach. There is also room for randomised control studies to 
determine the benefits of vitamin D supplementation in improving recovery after 
orthopaedic surgical interventions. Vitamin D supplementation, nutrition education, and 
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sun exposure education could be added as an intervention to improve vitamin D status 
and subsequently recovery from surgery. The study could be repeated with a study 
population including major orthopaedic surgical procedures such as hip replacements and 
back surgery where recovery periods are longer and sun exposure might be limited.  
 
In a diverse society such as South Africa, there is a need to produce credible data on the 
vitamin D status of the population and the needs of individuals with varying skin tones. The 
various stakeholders should work in partnership to achieve these goals.  
 
 
5.3 Study Limitations 
Study limitations included the small sample size, large percentage of minor surgical 
interventions and the low number of patients retained in the follow-up phase that limited 
the data on post-operative vitamin D status, intake and sun exposure. In future the study 
population can be increased to ensure equal representation between skin tone variation 
groups and more major surgical interventions. Follow-up period can be adjusted for short 
and long term impact of orthopaedic surgery. 
 
 
5.4 Declaration of Interest 
No declaration of interest. There were no conflicts of interest in this study. 
 
 
5.5 Deviations from Protocol 
In this private hospital setting, surgical follow-up was between one and two weeks, and 
this period was too short for the vitamin D status follow-up to be conducted. The follow-up 
period was extended from a month to 7–17 weeks in a bid to increase follow-up numbers. 
 
 
5.6 Sources of Support 
None. 
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Addendum A: Consent Form 
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
TITLE OF THE RESEARCH PROJECT: 
Vitamin D status among surgical orthopaedic patients in a private hospital in 
Johannesburg, South Africa 
PARTICIPANT NUMBER: 
PRINCIPAL INVESTIGATOR: Ronelle Vermaak (Dietician) 
ADDRESS: 
Mulbarton Hospital 
25 True North Road 
Mulbarton 
Medical Centre, Room 207 
CONTACT NUMBERS: 
011 432 3866 
083 463 1730 
You are invited to take part in a research project.  Please take some time to read the 
information presented here, which will explain the details of this project. Please ask the 
principal investigator, Ronelle Vermaak, any questions about any part of this project that 
you do not fully understand. It is very important that you are fully satisfied that you clearly 
understand what this research entails and how you could be involved. Also, your 
participation is entirely voluntary and you are free to decline to participate.  If you say no, 
this will not affect you negatively in any way whatsoever. You are also free to withdraw 
from the study at any point, even if you do agree to take part. 
This study has been approved by the Health Research Ethics Committee at 
Stellenbosch University and the Netcare Research Committee and will be conducted 
according to the ethical guidelines and principles of the international Declaration of 
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Helsinki, South African Guidelines for Good Clinical Practice, and the Medical Research 
Council (MRC) Ethical Guidelines for Research. 
 
What is this research study all about? 
The study will be conducted at Netcare Mulbarton Hospital, Johannesburg. A total of 87 
participants will take part in the study.  
In recent years, vitamin D has become a very hot topic in the research field. A recent study 
done in Israel (a sunny country) revealed vitamin D deficiency to be common. Vitamin D 
status has been done and studied globally in great detail. Studies on vitamin D status in 
Africa are few and far between, and most studies have been done on children. 
This led to the idea that vitamin D status needed to be investigated in South Africa. We 
assume that our vitamin D status is efficient because we live in a sunny country. We do 
not know if the recommendations of the Cancer Association (sunblock use, protective 
clothing) and our changes in lifestyle have had an impact on our vitamin D status. 
Associations can also be made between vitamin D status and other variables like weight, 
skin tone, sun exposure and food intake. 
In this study you will be asked questions about your food intake, time spent in the sun and 
sunblock use. Your age, sex, weight, waist circumference and skin tone will be recorded. 
All interviews and measurements will be done in private. A blood sample will be taken by 
Lancet Laboratories to measure your levels of vitamin D before your surgery and a follow- 
up blood test will be done on your vitamin D levels a month after your surgery. Your food 
intake and sun exposure will be recorded again a month after surgery at the follow-up visit.  
Why have you been invited to participate? 
All patients that have elective orthopaedic surgery booked at Mulbarton Hospital during the 
period April 2014 – September 2014 (pending on ethical approval) will be asked to 
participate in the study. 
What will your responsibilities be? 
You will not be asked to take any medication or supplements other than what your doctor 
prescribes. The responsibilities of participants in the research project will be to be truthful 
and honest when answering the questions about food intake, sun exposure, skin type and 
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personal information. Participants will be weighed and measured (height and waist 
circumference), and asked for a blood sample (to test vitamin D status) before surgery. 
Participants will be asked to attend a follow-up visit one month after surgery where another 
blood sample will be taken for vitamin D status and questions answered about food intake 
and sun exposure. 
Will you benefit from taking part in this research? 
There are no personal benefits from this study, but you will be part of a selected group of 
patients that will contribute to a study that will be the first of its kind done in South Africa. 
With these results it will be possible to determine if orthopaedic patients have vitamin D 
deficiency or are at risk of becoming vitamin D deficient after surgery and if vitamin D 
supplementation is needed in future. 
 
Are there in risks involved in your taking part in this research? 
There are minimal risks involved in participating in the study. The medical staff from 
Lancet Laboratories will take the utmost care to minimise any discomfort involved in taking 
blood samples. 
If you do not agree to take part, what alternatives do you have? 
There will be no consequences if you decide not to participate in the study.  
Who will have access to your medical records? 
Only the investigator (dietician), supervisors and statistician will have access to the 
information gathered during the study. All the information collected will be treated as 
confidential and protected. If used in a publication or thesis, the identity of the participants 
will remain anonymous.   
 
What will happen in the unlikely event of some form of injury occurring as a direct 
result of your taking part in this research study? 
In the event of injury occurring as a direct result of the research, the investigator has the 
appropriate insurance cover as specified by Netcare Hospitals. 
 
Will you be paid to take part in this study and are there any costs involved? 
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No, you will not be paid to take part in the study but the cost of all vitamin D blood tests will 
be covered by the researcher. There will be no costs involved for you if you do take part. If 
you incur any travel expenses to attend the follow-up visit, you will be reimbursed with a 
travel voucher to the maximum of R50. 
 
Is there anything else that you should know or do? 
 Your orthopaedic surgeon will be informed that you are taking part in the research 
study.   
 You can contact Ronelle Vermaak, the dietician, at 083 463 1730 if you have any 
further queries or encounter any problems. 
 You can contact the Health Research Ethics Committee at 021 938 9207 if you 
have any concerns or complaints that have not been adequately addressed by your 
study dietician. 
 You will receive a copy of this information and consent form for your own records. 
 
Declaration by participant 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled Vitamin D status among surgical orthopaedic patients in a 
private hospital in Johannesburg, South Africa 
I declare that: 
 I have read or had read to me this information and consent form and it is written 
in a language with which I am fluent and comfortable. 
 I have had a chance to ask questions and all my questions have been 
adequately answered. 
 I understand that taking part in this study is voluntary and I have not been 
pressurised to take part. 
 I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
 I may be asked to leave the study before it has finished, if the researcher feels it 
is in my best interests, or if I do not follow the study plan agreed to. 
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Signed at (place) ......................…........…………….. on (date) …………....……….. 2013. 
 
 ...............................................................  ............................................................. 
Signature of participant Signature of witness 
 
Declaration by investigator 
I (name) ……………………………………………..……… declare that: 
 
 I explained the information in this document to ………………………………….. 
 I encouraged him/her to ask questions and took adequate time to answer them. 
 I am satisfied that he/she adequately understands all aspects of the research, 
as discussed above. 
 I did/did not use an interpreter.  (If an interpreter is used then the interpreter 
must sign the declaration below.) 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 2013. 
 
 ...............................................................  ............................................................. 
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Addendum B: Anthropometric Measurements & Biochemical Data 
Participant Number  
Date D M Y 








3. Waist Circumference cm 
Male:  
<102cm 1 




4. BMI  kg/m² 
Underweight :<18.50 1 
Normal :18.50–24.99 2 
Overweight:     25.00–29.99 3 
Obese Class I:  30.00–34.99 4 
Obese Class II: 35.00–39.99 5 
Obese Class III:           ≥40 6 
5. 25-hydroxyvitamin D [25(OH)D] 
 
     First Reading (Pre-Operative): Date: 
ng/ml 
Undetectable: <5ng/ml  1 
Deficiency:         20ng/ml  2 
Insufficiency: <30ng/ml   3 
Optimum:         >30ng/ml   4 
Toxic                 >100ng/ml 5 
     8.  25-hydroxyvitamin D [25(OH)D] 
 
     Second Reading (Post-Operative): Date: 
ng/ml 
Undetectable: <5ng/ml  1 
Deficiency:         20ng/ml  2 
Insufficiency: <30ng/ml   3 
Optimum:         >30ng/ml   4 
Toxic                 >100ng/ml 5 
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Addendum C: Demographic Questionnaire 
Participant Number:  
Date D M Y 
1. Type of Surgery Hip Replacement 1 
Knee Replacement 2 
Shoulder 3 
Back 4 
Specify Other: 5 
2. Gender Male 1 
Female 2 
3. Age  
4. Date of Birth (for control purposes, do not code) D M Y 
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Specify Other: 5 
10.  Do you take any medication for your condition? Yes 1 
No 2 








13.  If yes, state medication and doses.  
 
 
14.  Do you take any supplements? Yes 1 
No 2 




16.  Do you smoke? Yes 1 
No 2 
17.  If no, have you smoked regularly before? Yes 1 
No 2 
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Addendum D: Skin Type Classification (The Fitzpatrick Skin Phototype Classification) 
Participant Number:  
Date D M Y 
 
The Fitzpatrick scale 
Type FZ I:    White skin, always burns, never tans 1 
Type FZ II:  White skin, always burns, minimal tan 2 
Type FZ III: White skin, burns minimally, tans moderately and gradually 3 
Type FZ IV:  Light brown skin, burns minimally, tans well 4 
Type FZ V:   Brown skin, rarely burns, tans deeply 5 
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Addendum E: Sun Exposure 
Participant Number:  











Weekdays    
< 15 minutes / day   1 
15 – 30 minutes / day   2 
30 – 60 minutes / day   3 
1 – 2 hours / day   4 
>2 hours / day   5 
Weekends    
< 15 minutes / day   6 
15 – 30 minutes / day   7 
30 – 60 minutes / day   8 
1 – 2 hours / day   9 
>2 hours / day   10 
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Usual attire during sun exposure. Choose one from every category: 
Clothing during the week 







Short pants Long pants No hat Hat 
       
 
Clothing during the weekend 







Short pants Long pants No hat Hat 
       
 











Short pants Long pants No hat Hat 











Short pants Long pants No hat Hat 
 0.36 0.04 0.14 0.24 0.00 0.07 0.03 
 
Sun exposure hours: BSA exposed Sun Index 
Week  Week   
Weekend  Weekend   
Weekly  Weekly   
Sun exposure X BSA = Sun Index 
Stellenbosch University  https://scholar.sun.ac.za
131 
 
Addendum F: Short Food Questionnaire for Vitamin D 
This form asks about your usual eating habits over the past month (dietician will fill in form)  
 For each food listed, mark the column to show how often, on average, you ate the food during the three 
months.   
 Please BE CAREFUL which column you put your answer in. 
 Mark whether your usual serving size is small, medium, or large.  Please DO NOT OMIT serving size. 
  
 Please DO NOT SKIP any foods. If you never eat a food, mark “Never or less that once a month”. 
 A small serving is one-half or less of the medium serving size shown. 
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 HOW MUCH OFFICE 
 

































































Cod liver oil              1   
Salmon, canned, drained              2   
Sardines, Canned in oil, drained              3   
Sardines, canned in tomato sauce              4   
Herring, grilled              5   
Kipper, baked (smoked herring)              6   
Butterfish, grilled              7   
Pilchards, canned in brine / tomato sauce              8   
Tuna, canned in oil, drained              9   
Egg, whole              10   
Liver, beef              11   
Liver, chicken              12   
Pork              13   
Beef              14   
Veal              15   
Cereal: Specify              16   
Cereal: Specify              17   
Margarine: Specify              18   
Milk Powder:              19   
Health Bar: Specify              20   
Health Bar: Specify              21   
 TOTAL  
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Addendum G: Lancet Laboratories venepuncture procedure118 
Activity Procedure Reason 
Preparation 
Greet Patient  Friendly  Good manners 
 The patient was made to feel 
welcome. 
Identify Patient  All in and out of hospital 
patients were identified  
 To ensure blood was being 





 Checked if the patient was 
fasting. 
 Checked if any information 
about medication needed to be 
recorded. 
 Made sure that the patient had 
signed consent for the tests 
being done. 
 Requirement for specimen 
collection. 
 Some results might be 
interpreted according to 
medication of the patient. 
Explained the 
procedure to the 
patient     
 Asked patient if he/she had had 
blood collected before; if not, 
briefly explained the procedure. 
 Ensured that the patient was 
aware of what was happening 
to them and allayed anxiety. 
Selected & prepared 
equipment 
 BD Vacutainer needle 21Gx1.5 
 Vacutainer holder tourniquet  
 Gloves 
 Alcohol swab 
 Cotton wool swab 
 Plaster 
 Was efficient and made sure 
that everything was ready, 
Chose correct 
containers/tubes 
 One SST tube (gold/rust) 
 5ml of blood drawn 
 For vitamin D test. 
Checked expiry 
date on tubes 
 Checked tube expiry dates   Accuracy of test results. 
Washed hands or 
sprayed 
 Used the Lancet hand-washing 
procedure. 
 Prevented the spread of 
infection. 
Latex allergy / 
Applied gloves  
 
 Gloves were worn for all 
procedures 
 Asked the patients if they were 
allergic to latex; if allergic to 
latex used Nitrile gloves (blue) 
 To protect sister and the 
patient from biohazards. 
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Activity Procedure Reason 
Positioned the 
patient 
 Sat or laid the patient down 
comfortably and in safe position. 
 Extended the patient’s arm in a 
downward position; made sure 
that the arm was supported. 
 Ensured that the patient was 




 Applied the tourniquet 10cm 
above the intended puncture 
site, tightened.  
 Did not leave the tourniquet 
tightened around the patient’s 
arm for longer than one minute. 
 The tourniquet caused the 
veins to bulge and made them 
prominent. 
Selected site  Asked the patient to close the 
fist. 
 Chose a suitable site and 
palpated the vein. 
 Ensured that the specimen 
was collected from a suitable 
site. 
Cleaned site  Used an alcohol swab, cleaned 
the selected site in a circular 
motion. 
 Ensured clean procedure. 
Showed patient 
sealed needle 
 Told the patient that the needle 
was sealed and showed it to 
him/her. 
 Gave the patient confidence 





 Performed the venepuncture 
procedure. 
 The needle was not be bent. 
 
Advanced tubes 
onto the vacutainer 
assembly 
 Made sure that the vacutainer 
holder was kept steady while 
attaching the tubes. 
 Filled the tubes with blood. 




 Once blood flow was 
established, the tourniquet was 
loosened. 
 
 Ensured accurate results. 
 Prevented bruising. 
Mixing of tubes / 
Inverting 
Mixed the tubes by inverting them 
gently 5–6 times 
 Mixed the additive in the tube 
with the blood, promoted 




 The blood flow was stopped with 
a cotton swab. 
 The needle was removed and 
was discarded in the sharps bin 
immediately. 
 
 Stopped the flow of blood and 
prevented a haematoma from 
forming. 






Activity Procedure Reason 
Asked about plaster 
allergy / Applied 
plaster 
 
 Asked about plaster allergy 
before applying plaster. 
 Kept the venepuncture site 
covered. 
Completion 
Disposal of waste 
material 
 Ensured that material was 
disposed of in the correct waste 
container. Only material that 
was in contact with the patient 
and the patient’s body fluids was 




 Prevented unnecessary 
exposure to bio-hazardous 
materials. 
Labelled tubes:  
 Patient details        
 Wrote down the patient’s 
surname, initials and date of 
birth or identity number as well 
as the gender of the patient, i.e. 
M/F. 
 Ensured that the specimen 
did not get muddled up with 
another patient’s specimen. 
Barcoded  tubes& 
form 
 Placed barcode straight as close 
to the top of the tube as 
possible. 
 Ease of scanning and 
processing throughout the 
laboratory system was 
ensured. 
Packaged tubes  Tubes were put in the clear side 
of the specimen bag, so that 
they could be seen and closed 
the Ziploc section. 
 For safe secure transportation 
of the specimen. 
Washed hands  As per the Lancet hand-washing 
protocol. 
 Prevented cross-infection 
between patients and 
ensured personal hygiene. 
Transported 
specimens 
 Specimens were packed in a 
cooler for transport. 
 Specimens were send to Lancet 
main laboratory (Richmond, 
Johannesburg). 
 Results were available 
within 48 hours. 
 Specimen were kept for 7 
days if further test were 
required 
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